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RÉSUMÉ 
Durant les dernières années, l’encapsulation d’îlots pancréatiques endocriniens a reçu une 
grande attention parce qu’elle pourrait constituer une solution pour diminuer les taux d'échecs 
des transplantations. Dans le contexte de la perte de la matrice extracellulaire (MEC) native 
des îlots lors de leur isolation et le rejet de greffes par le système immunitaire du receveur, 
cette thèse vise à améliorer la compréhension des interactions entre la MEC et les cellules des 
îlots pancréatiques endocriniens ainsi qu’à étudier les effets de stress apoptotiques associés à 
des éléments du système immunitaire sur la survie et les fonctions des îlots. Ces études 
pourraient permettre de raffiner notre compréhension des mécanismes associés au rejet des 
greffes d'îlots de Langerhans. 
Dans cette thèse, le premier chapitre constitue une revue de la littérature permettant de mettre 
en lumière les rôles réciproques de la MEC dans l'action des cellules immunitaires et 
l'influence de ces rôles sur le diabète de type 1 (DT1) et sur la transplantation d'îlots. Ce 
premier chapitre a été publié dans la revue Pathologie Biologie. 
Le premier travail expérimental comprend la culture de cellules d'insulinomes de rat (INS-1) 
sur des surfaces composées de carboxyméthyl dextrane (CMD) recouvertes de fibronectine, 
RGD ou YIGSR, un peptide synthétique de la laminine. Dans cette étude, l'effet bénéfique 
d’éléments de la MEC sur ces cellules productrices d'insuline a été démontré. Les cellules 
INS-1 ont davantage proliféré sur ces surfaces et sécrétaient plus d’insuline que les cellules 
INS-1 cultivées sur les surfaces contrôle de CMD, CMD+RGE et dans les plaques à multi-
puits de polystyrène vendues pour la culture tissulaire (TCPS). Cette première étude a été 
publiée dans Acta Biomaterialia. 
La deuxième étude expérimentale avait pour objectif d’étudier l’effet protecteur de gels de 
fibrine pour enrober des îlots pancréatiques endocriniens isolés de jeunes porcs et exposés à  
deux concentrations de peroxyde d'hydrogène (H2O2). L’enrobage dans la fibrine a permis de 
réduire l'apoptose chez les cellules des îlots et d’améliorer la sécrétion d'insuline par ceux-ci 
lorsque les résultats étaient comparés à ceux des îlots non-enrobés. Ce travail a été publié dans 
la revue Islets. 
Dans la troisième étude expérimentale, des îlots porcins étaient enrobés dans des gels de 
fibrine et d'alginate et exposés à des monocytes humains pour comparer l’effet de l’enrobage 
par ces deux matériaux sur la survie et les fonctions des îlots. Les monocytes sécrétaient des
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concentrations importantes de cytokines TNFα, IL-6, IL-1β en réponse à la fibrine seule et aux 
îlots. Les cellules des îlots enrobés dans les gels de fibrine et d'alginate étaient moins 
apoptotiques et sécrétaient plus d'insuline que leurs contrôles respectifs non-enrobés. Cette 
étude a été acceptée dans la revue Pathologie Biologie. 
 
Mot clés: Modification de surface; Diabète; Sécrétion d’insuline; Transplantation d’îlots; 
Encapsulation d’îlots; Système immunitaire et monocytes. 
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ABSTRACT 
In recent years, the encapsulation of endocrine pancreatic islets has received enhanced 
attention as it might constitute a solution for islet transplantation failure. In the context of the 
loss of the native islet extracellular matrix (ECM) and graft rejection by the recipient’s 
immune system, this thesis aims to improve the understanding of ECM-islet cell interactions 
and immune system-related implications in islet survival and function in the context of type 1 
diabetes mellitus (T1DM) and islet graft rejection. 
In the first chapter, a literature review introduces the reciprocal roles of the ECM in immune 
cell action and the influence of these interactions on T1DM and islet transplantation. The most 
important ECM components are discussed followed by an overview of immune cells and their 
possible implication in diabetes. Immune cell integrins and cytokines and their communication 
with and influence on ECM are highlighted, concluding in a brief discussion of the 
significance of these interactions for islet transplantation and encapsulation. This review has 
been accepted for publication by Pathologie Biologie. 
The first experimental work comprises the culture of rat insulinoma cells (INS-1) on well-
defined low-fouling carboxymethyl-dextran (CMD) surfaces covalently grafted with 
fibronectin, RGD and YIGSR, a synthetic laminin peptide, resulting in higher cell 
proliferation and insulin secretion of INS-1 cells when compared to the controls CMD, 
CMD+RGE and tissue culture polystyrene (TCPS) plates. With this work, the beneficial effect 
of ECM cues on insulin-producing cells was proven. This study has been published in Acta 
Biomaterialia. 
The second experimental work aimed to study the effect of fibrin gels when used to embed 
endocrine pancreatic islets isolated from young pigs and exposed to hydrogen peroxide 
(H2O2). Fibrin-embedded islets showed less apoptosis and higher relative insulin secretion 
than islets on TCPS, verifying the protective effect of fibrin towards islets. This study has 
been published in Islets. 
In the third experimental study, porcine islets were encapsulated in fibrin and alginate gels and 
exposed to human monocytes to compare the two materials and to further investigate the 
immune protective properties of fibrin and alginate. Monocytes secreted high concentrations 
of TNFα, IL-6, and IL-1β in response to fibrin, but at the same time islets in both fibrin and 
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alginate gels were less apoptotic and secreted more insulin then their TCPS controls. This 
study has been submitted to Pathologie Biologie. 
 
Keywords: Surface modification; Diabetes; Insulin secretion; Islet transplantation; Islet 
encapsulation; Immune system; Human monocytes. 
  
v 
 
ACKNOWLEDGEMENTS 
 
First, I would like to thank my research director Prof. Patrick Vermette for the opportunity to 
work on this project and perform scientific research in a field I was always most interested in. 
His support and guidance encouraged me to advance my research and allowed me to grow as a 
research scientist. 
I would like to thank the members of my jury for taking the time to read and evaluate this 
thesis. Their constructive criticism will make this work better. 
I would also like to thank Prof. Tamàs Fülöp and his research group at the Université de 
Sherbrooke for providing me with their laboratory, donor blood and the technique to separate 
monocytes. 
My thanks go out to Dr. Jonathan Lakey and his entire laboratory for the generous and 
unrestrictive supply of porcine islets. 
I am grateful to my group members, Justin Dubois, Andriy Shkilnyy, Sylvain Vigier and 
Rajesh Damodaran, at the Université de Sherbrooke, for sharing the literature, pleasant lab 
hours, scientific discussions and invaluable assistance. Special thanks go to Georges Sabra and 
Dr. Evan A. Dubiel, who provided me with insights to the surface modification they 
developed and which I applied for my first paper. I want to express my gratitude to Jamie 
Sharp whose friendship and scientific companionship helped me through the hard times. 
I would like to thank my partner, Martin, for his love and support he has shown during the past 
years it took me to finalize this thesis. I am thankful to his family for welcoming me in their 
home and lives. 
Words cannot express how grateful I am to my family. Especially my mother, Sabine Kuehn, 
and my brother, Thomas Kuehn, supported me immensely over those 4 years having been so 
far away from home. I am grateful to my father, Heinrich Kuehn, for his ongoing support. I 
want to dedicate this thesis to my family. 
  
vi 
 
TABLE OF CONTENTS 
RÉSUMÉ             i 
ABSTRACT           iii 
ACKNOWLEDGEMENTS           v 
LIST OF FIGURES           xi 
LIST OF TABLES          xiv 
LIST OF ABBREVIATIONS         xv 
Chapter 1 INTRODUCTION           1 
Chapter 2 Cross Talk Between the Extracellular Matrix and the Immune System 
in the Context of Endocrine Pancreatic Islet Transplantation      5 
 Foreword            6 
 2.1 Abstract           8 
 2.2 Introduction           9 
 2.3 The Extracellular Matrix         9 
  2.3.1  ECM Components        10 
  2.3.2  Glycosaminoglycans        10 
  2.3.3  Collagens         10 
  2.3.4  Fibronectin         11 
  2.3.5 Integrins         12 
  2.3.6 Laminins         12 
  2.3.7 Fibrin as a Transient Component of the ECM    13 
vii 
 
  2.3.8 ECM of the Human Endocrine Pancreatic Islets    13 
 2.4 The Immune System         14 
  2.4.1 Innate and Adaptive Immune Systems     14 
  2.4.2 Immune Cells         15 
   2.4.2.1 Neutrophils        15 
   2.4.2.2 Granulocytes: Eosinophils, Basophils and Mast cells  16 
   2.4.2.3 Natural Killer Cells       17 
   2.4.2.4 Dendritic Cells       17 
   2.4.2.5 Monocytes and Macrophages      17 
   2.4.2.6 T Lymphocytes       18 
   2.4.2.7 B Lymphocytes       19 
   2.4.2.8 Cytokines        19 
  2.4.3 Type 1 Diabetes Mellitus       20 
  2.4.4 Islet Transplantation        21 
 2.5 Interactions between the ECM and the Immune System    22 
  2.5.1 Integrins of Immune Cells       22 
  2.5.2 The ECM and Cytokines       25 
  2.5.3 Implications of ECM-Mediated Immune Response in Wound  
Healing in the Context of Islet Transplantation    27 
 2.6 Conclusions          29 
Chapter 3 Culturing INS-1 Cells on CDPGYIGSR-, RGD- and Fibronectin Surfaces  
Improves Insulin Secretion and Cell Proliferation       31 
 Foreword           32 
 3.1 Abstract          34 
 3.2 Introduction          35 
viii 
 
 3.3 Experimental Section         36 
  3.3.1 Surface Preparation        36 
  3.3.2 X-ray Photoelectron Spectroscopy (XPS)     37 
  3.3.3 Cell Culture         37 
  3.3.4 Glucose-Stimulated Insulin Secretion (GSIS)    37 
  3.3.5 Immunofluorescence        38 
  3.3.6 Ki-67 and Pdx1 Analysis       39 
  3.3.7 Assay for Assessing Cell Number      39 
  3.3.8 Statistical Analysis        39 
 3.4 Results and Discussion        39 
 3.5 Conclusions          50 
 3.6 Acknowledgements         50 
Chapter 4 Young Porcine Endocrine Pancreatic Islets Cultured in Fibrin Show  
Improved Resistance Towards Hydrogen Peroxide       52 
 Foreword           53 
 4.1 Abstract          55 
 4.2 Introduction          56 
 4.3 Results          57 
  4.3.1 Islets in Fibrin Maintained Their Typical Morphology Whereas  
Islets Cultured in TCPS Plates Dispersed     57 
  4.3.2 Islets Cultured in Fibrin Maintained Their Responsiveness to  
Glucose Concentrations and Secreted More Insulin than Islets  
in TCPS Plates        58 
4.3.3 Insulin and Glucagon Expression is Diminished in Islets  
Cultured in TCPS Plates       61 
  4.3.4 Integrin α5 is Strongly Expressed in Fibrin-Embedded Islets  62 
  4.3.5 Fibrin Embedding Protects Islets Against Apoptosis    63 
 4.4 Discussion          65 
 4.5 Materials and Methods        67 
  4.5.1 Isolation of Young Porcine Endocrine Pancreatic Islets   67 
  4.5.2 Young Endocrine Porcine Islet Culture     68 
ix 
 
  4.5.3 Islet Incubation with Hydrogen Peroxide (H2O2)    68 
  4.5.4 Glucose-stimulated Insulin Secretion (GSIS) and Insulin  
Entrapment in Fibrin Gels       68 
  4.5.5 Immunofluorescence        69 
  4.5.6 TUNEL Apoptosis Assay       70 
  4.5.7 Statistical Analysis        70 
 4.6 Acknowledgements         71 
Chapter 5 Young Porcine Endocrine Pancreatic Islets Cultured in Fibrin and  
Alginate Gels Show Improved Resistance Towards Human Monocytes    72 
 Foreword           73 
 5.1 Abstract          75 
 5.2 Introduction          76 
 5.3 Materials and Methods        78 
  5.3.1 Isolation of Young Porcine Endocrine Pancreatic Islets   78 
  5.3.2 Young Endocrine Porcine Islet Culture     78 
  5.3.3 Separation of Monocytes from Human Whole Blood   78 
  5.3.4 Preparation of Fibrin and Alginate Gels Containing Young  
Porcine Endocrine Islets       79 
  5.3.5 Islet Incubation with Human Monocytes     80 
  5.3.6 Cytokine Secretion        81 
  5.3.7 Insulin Secretion from Young Porcine Endocrine Pancreatic  
Islets          81 
  5.3.8 Immunofluorescence        82 
  5.3.9 TUNEL Apoptosis Assay       82 
  5.3.10 Statistical Analysis        83 
 5.4 Results          83 
  5.4.1 Monocyte Migration Towards Young Porcine Pancreatic Islets  83 
  5.4.2 Levels of TNFα, IL-1β and IL-6 Secreted by Monocytes are the  
Highest in Fibrin        85 
  5.4.3 Islets in Fibrin and Alginate are Less Apoptotic than Islets  
in TCPS Plates        88 
x 
 
5.4.4 Islets in Fibrin and Alginate Secrete Higher Levels of Insulin  
than Islets in TCPS        90 
  5.4.5 Integrins αVβ3 and α5 Are Expressed More Profoundly in Fibrin  
Islet Cultures         91 
  5.4.6 CD14 Is Expressed in Both Monocytes and Porcine Pancreatic  
Islets          92 
 5.5 Discussion          95 
 5.6 Conclusions          98 
 5.7 Acknowledgements         99 
Chapter 6 CONCLUSIONS         100 
LIST OF REFERENCES         110 
APPENDIX A          134 
APPENDIX B           139 
 
 
  
xi 
 
LIST OF FIGURES 
Figure 2.1: Schematic presentation of leukocyte recruitment to the site of inflammation  
(left) and immune cell response in tissue injury (right)      26 
Figure 2.2: Schematic presentation of the immune response during islet grafting  
(left), instant blood-mediated inflammatory reaction (IBMIR) and islet encapsulation  
(right)               29 
 
Figure 3.1: High resolution XPS C 1s spectra of CDPGYIGSR, fibronectin, RGD  
and RGE surfaces and interlayers         41 
Figure 3.2: INS-1 cell number after 7 days of culture on the different surfaces   42 
Figure 3.3: Percentage of INS-1 cells stained positively for Ki-67 after 7 days of culture  
on the different surfaces          42 
Figure 3.4: Phase contrast microscopy pictures of INS-1 cells grown on the different  
surfaces after 72 h            44 
Figure 3.5: Expression of integrins α5 (red) and αVβ3 (green) of INS-1 cells  
cultured for 7 days on the different surfaces        46 
Figure 3.6: Immunofluorescence staining for E-cadherin of INS-1 cells cultured  
for 7 days on CMD and RGE          47 
Figure 3.7: Glucose-stimulated insulin secretion (GSIS) of INS-1 cells cultured  
on different surfaces for 7 days         48 
Figure 3.8: Percentage of INS-1 cells stained positively for Pdx1 after 7 days of  
culture on the different surfaces         50 
 
Figure 4.1: Morphology of young porcine endocrine pancreatic islets cultured for  
12 h in TCPS plates with no H2O2 (A), 10 µM H2O2 (B) and 100 µM H2O2 (C).  
Morphology of islets cultured for 12 h in fibrin with no H2O2 (D), 10 µM H2O2 (E)  
and 100 µM H2O2 (F).          57  
Figure 4.2: (A) Relative insulin secretion of young porcine endocrine pancreatic islets  
after 1h stimulation with low glucose concentration (LG, 2.8 mM), high glucose  
concentration (HG, 28 mM), high glucose concentration +  
xii 
 
3-isobutyl-1-methylxanthine (IBMX) (HI, 28 mM + IBMX) and a second  
low glucose concentration (LG2, 2.8 mM). (B) Three repeats of a glucose-stimulated  
insulin secretion assay with LG, HG, HI and a final LG. Shown are the insulin contents  
in the media (µg per L) of porcine pancreatic islets (200 IEQ) cultured on TCPS (T)  
or in fibrin gels (F) with 0, 10 or 100 µM H2O2       59 
Figure 4.3: Mass of insulin (in µg) secreted into the media by 200 IEQ embedded in fibrin  
and exposed to 0 (F0) and 100 µM H2O2 (F100) and the mass of insulin (in µg) in the  
extract of fibrin gels rinsed with 500 µL PBS and centrifuged thereafter     60  
Figure 4.4: Immunofluorescence staining for insulin (green) and glucagon (red) of young 
porcine endocrine pancreatic islets          61 
Figure 4.5: Immunofluorescence staining for integrin α5 (red) of young porcine endocrine 
pancreatic islets            63 
Figure 4.6: Light microscopy images of young porcine endocrine pancreatic islets treated  
with the APO-BrdU IHC staining kit. Islets cultured in TCPS plates with 0, 10 or  
100 µM H2O2 compared to time zero (A) and islets embedded in fibrin with 0, 10 or  
100 µM H2O2 compared to time zero (B) are shown. The percentage of apoptotic cells  
(brown) in the total cell population (blue and brown) is shown in Fig. 4.6C     64 
 
Figure 5.1: Schematic representation of the islet-monocyte co-culture systems with  
non-encapsulated islets in a TCPS well and islets encapsulated in fibrin or alginate  80 
Figure 5.2: Morphology of young porcine endocrine pancreatic islets and human  
monocytes cultured for 8 h in TCPS plates, alginate, of fibrin     84 
Figure 5.3: Morphology of young porcine endocrine pancreatic islets and human  
monocytes cultured for 24 h in TCPS plates, alginate, or fibrin     85 
Figure 5.4: Secretion of cytokines TNFα, IL-6, and IL-1β in the culture media of  
young porcine endocrine pancreatic islets cultured alone or co-cultured with  
human monocytes, and human monocytes cultured alone for 24 h in TCPS plates,  
alginate, or fibrin            87 
Figure 5.5: Light microscopy images of young porcine endocrine pancreatic islets and  
human monocytes treated with the APO-BrdU IHC staining kit to reveal apoptotic  
cells. TCPS: Islets (A), islets+monocytes (B), and monocytes (C). Fibrin:  
xiii 
 
Islets (D), islets+monocytes (E), and monocytes (F). Alginate: Islets (G),  
islets+monocytes (H), and monocytes (I)         89 
Figure 5.6: Percentage of apoptotic cells in the indicated cell population of young  
porcine endocrine pancreatic islets and human monocytes either cultured alone or  
co-cultured in alginate, fibrin or TCPS plates and treated with the APO-BrdU IHC  
staining kit to reveal apoptotic cells         89  
Figure 5.7: Insulin secretion per IEQ from young porcine endocrine pancreatic islets  
after a 24-h culture in TCPS, alginate, or fibrin with and with no human monocytes  90 
Figure 5.8: Immunofluorescence staining for integrins αVβ3 (green) and α5 (red) of  
young porcine endocrine pancreatic islets after a 24-h culture in TCPS plates, alginate,  
or fibrin with and with no human monocytes         91 
Figure 5.9: Immunofluorescence staining for CD14 (green) and E-cadherin (red) of  
young porcine endocrine pancreatic islets after a 24-h culture in TCPS plates, alginate,  
or fibrin with and without human monocytes         93 
 
Figure A1: Immunofluorescence staining for Ki-67 of INS-1 cells cultured for  
7 days on TCPS and RGE         134 
Figure A2: Expression of integrins α5 (red) and αVβ3 (green) of INS-1 cells cultured for  
7 days on the different surfaces        135 
Figure A3: Expression of integrins α5 (red) and αVβ3 (green) of INS-1 cells cultured for  
3 days on the different surfaces        136 
Figure A4: Immunofluorescence staining for E-cadherin of INS-1 cells cultured for  
3 days            137 
Figure A5: Immunofluorescence staining for insulin of INS-1 cells cultured for 7 days on 
fibronectin           138 
Figure A6: Immunofluorescence staining for Pdx1 of INS-1 cells cultured for  
7 days on CDPGYIGSR and RGE        138 
 
Figure B1: SEM images of fibrin and alginate gels      139 
Figure B2: Photography of fibrin and alginate gels in a 12-well plate   139 
  
xiv 
 
LIST OF TABLES 
Table 3.1: XPS atomic concentration (%) and atomic ratio of HApp,  
HApp+CMD, HApp+CMD+CDPGYIGSR, HApp+CMD+Fibronectin,  
HApp+CMD+RGD and HApp+CMD+RGE        40 
 
Table 4.1: Number of cells stained positively for glucagon, insulin, and both  
glucagon and insulin, counted on immunofluorescence images of porcine pancreatic  
islets at ‘Time Zero’, in fibrin with no (F0), 10 (F10), and 100 (F100) µM H2O2,  
and on TCPS with no (T0), 10 (T10), and 100 (T100) µM H2O2     62 
Table 4.2: Number of cells stained positively for integrin α5, counted on  
immunofluorescence images of porcine pancreatic islets at ‘Time Zero’, in fibrin with  
no (F0), 10 (F10), and 100 (F100) µM H2O2, and on TCPS with no (T0), 10 (T10),  
and 100 (T100) µM H2O2           63 
 
Table 5.1: Manual counting of cells in all conditions stained positively for integrins αVβ3  
and α5              92 
Table 5.2: Analysis of islet and monocyte cultures stained for E-cadherin and CD14  94  
 
  
xv 
 
LIST OF ABBREVIATIONS 
3D   three dimensional 
ANOVA  analysis of variance 
APC   antigen-presenting cells 
bFGF   basic fibroblast growth factor 
BM   basement membrane 
BSA   bovine serum albumin 
CaCl2   calcium chloride 
CDPGYIGSR  synthetic laminin pentapeptide Tyr-Ile-Gly-Ser-Arg 
CMD   carboxymethyl-dextran 
CO2   carbon dioxide 
DAB   3,3'-diaminobenzidine 
DAPI   4’, 6-diamidino-2-phenylindole, dihydrochloride 
DC   dendritic cells 
DNA   deoxyribonucleic acid 
ECM    extracellular matrix 
ELISA   enzyme-linked immunosorbent assay 
FACS   fluorescence-activated cell sorting 
FBS   fetal bovine serum 
FN   fibronectin 
GAG   glycosaminoglycan 
xvi 
 
GSIS   glucose-stimulated insulin secretion 
H2O2   hydrogen peroxide  
HApp   n-heptylamine plasma polymer 
HG   high glucose 
HI   high glucose + IBMX 
IBMIR   instant blood-mediated inflammatory reaction 
IBMX   3-isobutyl-1-methylxanthine 
IEQ   islet equivalent 
IFN   interferon 
IL   interleukin 
INS-1   rat insulinoma cells 
KRBH   Krebs-Ringer buffer with HEPES 
LFA   leukocyte function-associated antigen 
LG   low glucose 
LPS   lipopolysaccharides 
MHC   major histocompatibility complex 
MIN-6   mouse insulinoma cells 
MMP   matrix metalloproteinase 
NK   natural killer cells 
P   probability 
Pdx1   pancreatic and duodenal homeobox 1  
xvii 
 
RGD   Arg-Gly-Asp 
RGE   Arg-Gly-Glu 
RT   room temperature 
RT-PCR  real time polymerase chain reaction 
T1DM   type 1 diabetes mellitus 
TCPS   tissue culture polystyrene 
TGF   transforming/tumor growth factor 
TNF   tumor necrosis factor 
TUNEL  terminal deoxynucleotidyl transferase dUTP nick end labeling 
VCAM  vascular cell adhesion molecule 
XPS   X-ray Photoelectron Spectroscopy 
 
 1 
 
Chapter 1 
 
INTRODUCTION 
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Islet transplantation is considered to be a promising treatment if not a cure for Type 1 Diabetes 
mellitus (T1DM). With more than 346 million people worldwide being affected by diabetes, 
the impact on the international health system and the life quality of patients is apparent [1]. 
Between 5 and 7 % of diabetes patients suffer from the autoimmune form, T1DM, 
characterized by the loss of endogenous insulin production. A combination of genetics and 
environmental factors leads to the onset of T1DM through an immune system-mediated 
destruction of insulin-producing β-cells within the endocrine Langerhans’ islets in the 
pancreas. Lifelong insulin therapy comprising constant blood glucose monitoring and insulin 
injections is required for T1DM treatment. Even though advances have been made in this 
field, such as automatic monitoring and insulin pumps, in some cases the regulation of blood 
glucose levels is extremely difficult. The once fatal disease has become treatable but T1DM 
diagnosis still implicates reduced life expectancy and a wide range of acute and chronic 
secondary complications such as hypo- and hyperglycemia, ketoacidosis, diabetic coma, and 
macro- and microvascular diseases [2]. 
For patients with uncontrolled blood glucose levels, pancreatic islet transplantation has 
become a promising alternative [3]. The idea of islet transplantation, as opposed to whole 
pancreas transplantation, is to replace the tissue affected by the autoimmune destruction. 
Therefore, islets are enzymatically, mechanically and chemically disrupted from the 
surrounding exocrine tissue [4,5]. In most cases, the purified islet graft is then injected into the 
patient’s portal vein or else, co-transplanted with a donor kidney [6]. Since organ donor 
shortage is one of the primary limitations of islet transplantation, xenotransplantation (i.e. 
porcine islet transplantation into human patients) has moved into the focus of research. Other 
limitations are based on islet graft function and cell loss due to multiple factors [7]. Among 
those is the loss of islet extracellular matrix (ECM) during islet isolation and the response of 
the host’s immune system to the allograft [8]. In recent years, both islet-ECM interactions and 
graft-immune response dynamics have been studied widely and islet encapsulation approaches 
have emerged as potential solution for both problems [9]. Encapsulation materials can be 
altered with ECM cues to support islet structure and function and could simultaneously protect 
the islet graft from immune cell invasion and consequent destruction. 
This thesis aims to help understand underlying implications of the immune system in islet cell 
destruction in both T1DM and islet transplantation and the postulated beneficial effect of  
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ECM-related cell interactions. It was hoped to determine the feasibility of islet encapsulation 
in the context of graft rejection, ECM and structural support, and maintenance of islet cell 
viability and function. 
To study the interaction of insulin-producing cells with the ECM, rat insulinoma cells (INS-1) 
were used [10]. INS-1 cells were cultured on fibronectin, RGD (Arg-Gly-Asp) and a synthetic 
laminin pentapeptide (YIGSR), specifically grafted on carboxymethyl-dextran (CMD) 
surfaces, to assess their morphology, viability, and function i.e., insulin secretion in response 
to different glucose concentrations. The objective was to find conditions that would improve 
the insulin secretion and proliferation of insulin-producing cells. To address the ongoing 
research in xenotransplantation and islet encapsulation, young porcine endocrine pancreatic 
islets were embedded in fibrin and later alginate gels and either exposed to two hydrogen 
peroxide (H2O2) concentrations or later, to human monocytes. It was hypothesized that fibrin- 
and/or alginate-embedded islets would show improved integrity after isolation, maintained 
glucose-responsiveness and insulin secretion, and resistance towards mediators of the immune 
system. 
 
Chapter 2 of this thesis titled, “Cross Talk Between the Extracellular Matrix and the Immune 
System in the Context of Endocrine Pancreatic Islet Transplantation”, is a review of most 
important ECM components, immune cells, the interactions of ECM and immune cells, and 
their implication in T1DM and islet transplantation. As islet transplantation research is trying 
to exploit the beneficial potential of ECM-islet cell interactions, this review highlights now 
known reciprocal action of immune cells, their specific integrins, and the ECM with a focus 
on islet transplantation and T1DM development. 
In Chapter 3 titled, “Culturing INS-1 Cells on CDPGYIGSR-, RGD- and Fibronectin Surfaces 
Improves Insulin Secretion and Cell Proliferation”, INS-1 cells were cultured on specifically 
modified surfaces with well-defined properties, grafted with various ECM cues to improve 
cell proliferation and insulin secretion. In comparison with the controls – tissue culture 
polystyrene (TCPS) plates, CMD surfaces and RGE surfaces – YIGSR-, RGD- and fibronectin 
surface-cultured INS-1 cells showed higher net cell numbers after 7 days of culture and 
enhanced insulin secretion in response to glucose. Interestingly, INS-1 cells on the low-fouling 
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surfaces CMD and RGE stayed in suspension and remained functional, forming so called 
“pseudo-islet” structures. 
  
In Chapter 4 titled, “Young Porcine Endocrine Pancreatic Islets Cultured in Fibrin Show 
Improved Resistance Towards Hydrogen Peroxide”, islets were embedded in fibrin gels or 
cultured on TCPS and exposed to 10 and 100 µM H2O2 for 12 h. Consequent analysis revealed 
maintained insulin secretion of fibrin-embedded islets whereas TCPS-cultured islets lost their 
glucose-responsiveness with increasing H2O2 concentrations. Islets in fibrin were also less 
apoptotic and expressed higher levels of α5 integrin as well as insulin and glucagon. 
 
Chapter 5 titled, “Young Porcine Endocrine Pancreatic Islets Cultured in Fibrin and Alginate 
Gels Show Improved Resistance Towards Human Monocytes”, included alginate gels as 
another promising encapsulation material. Human monocytes were used to further highlight 
the xenotransplantation approach and to possibly establish an in vitro model for T1DM and 
immune responses to islet grafts. Fibrin alone evoked a strong cytokine secretion of TNFα, IL-
6 and IL-1β, but islets in fibrin and alginate were less apoptotic and secreted more insulin than 
islets on TCPS. Integrin expression was higher in fibrin-embedded islets and monocyte-
presence enhanced αVβ3 expression in all conditions. 
 
In Chapter 6, titled “Conclusion”, the outcome of this thesis is discussed and future directions 
are suggested. 
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Chapter 2 
 
CROSS TALK BETWEEN THE EXTRACELLULAR 
MATRIX AND THE IMMUNE SYSTEM IN THE 
CONTEXT OF ENDOCRINE PANCREATIC ISLET 
TRANSPLANTATION 
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Titre en français : 
Interactions entre la Matrice Extracellulaire et le Système Immunitaire dans le Contexte de la 
Transplantation d’Îlots Pancréatiques Endocriniens 
 
Résumé 
Cette revue de la littérature a pour but de mettre en évidence l’importance des interactions 
bidirectionnelles de la matrice extracellulaire (MEC) et des cellules du système immunitaire 
dans le contexte du diabète de type 1 (DT1) et de la transplantation d'îlots pancréatiques 
endocriniens. Nous faisons un survol des grandes classes de molécules qui composent la MEC 
ainsi que les protéines, cellules et cytokines impliquées dans le système immunitaire. Cet 
article examine aussi les rôles de la MEC et du système immunitaire dans la transplantation 
d'îlots pancréatiques et plus particulièrement les effets des intégrines exprimées par les cellules 
du système immunitaire et leurs fonctions. Finalement, les cytokines liées à la MEC et leur 
influence sur les cellules immunitaires et la MEC sont abordées. 
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2.1 Abstract 
 
This review aims to highlight the importance of the bidirectional influence of the extracellular 
matrix (ECM) and immune cells in the context of type 1 diabetes mellitus (T1DM) and 
endocrine pancreatic islet transplantation. We introduced the main classes of molecules and 
proteins constituting the ECM as well as cells and cytokines of the immune system with the 
aim to further examine their roles in T1DM and islet transplantation. Integrins expressed by 
immune cells and their functions are detailed. Finally, this article reviews the roles of the 
ECM and the immune system in islet transplantation as well as ECM-related cytokines and 
their influence on the ECM and immune cells. 
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2.2 Introduction 
 
The extracellular matrix (ECM) was long considered to be solely the non-cellular connective 
tissue and served mainly as mechanical support for the surrounding cells. Now it is known that 
apart from a structural support, the ECM is fulfilling functions such as tissue segregation, 
regulation of intercellular communication, storage and activation of growth factors and 
cytokines, as well as mediation of cell development, growth, survival, adhesion and migration 
[11]. The immune system was long believed to act on its own but it emerges now that 
interactions with other cells, integrins, growth factors, cytokines and the ECM play a pivotal 
role in immune cell development, maturation, and function [12]. In this review, the specific 
role of the ECM in the immune system is investigated. A highlight will be set on type 1 
diabetes mellitus (T1DM) and pancreatic islet transplantation. 
 
2.3 The Extracellular Matrix 
 
There are two major categories of ECM, the basement membrane (BM) and the interstitial or 
stromal ECM. The BM is a thin layer, between 50- and 100-nm thick, of a specialized ECM 
made up of collagen, laminin, and fibrillin (microfibrils), separating the epithelial or 
endothelial tissue from the connective tissue. Besides providing a structural support to cells, 
the BM modifies the cellular behavior via outside-in signalling. The structure, composition, 
and function of the BM is organ-specific [13]. 
The interstitial or stromal ECM is a tissue of high complexity and variety. It constitutes a 
network of multiple proteins and polysaccharides. Those are secreted by local cells and stay 
closely associated to the surface of those cells that produced them. After secretion, the ECM 
proteins and polysaccharides are assembled into a highly organized meshwork [14]. There is a 
great diversity in ECM organization and different types of matrix proteins and 
polysaccharides. This diversity results in different types of ECM, each formed depending on 
the function of the particular tissue e.g., hard, mineralized structures for bone or teeth, soft 
ECM in internal organs, transparent layers of the cornea, and strung ECM in tendons [14]. 
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2.3.1 ECM Components 
 
The two main classes of extracellular macromolecules that make up the matrix are namely: 
• polysaccharide chains of glycosaminoglycans (GAGs), which are usually found 
covalently linked to proteins in the form of proteoglycans; 
• fibrous proteins, including collagens, elastin, fibronectin (FN), and laminins.  
Whereas proteoglycans constitute the basic substance of ECM by forming a gel-like hydrated 
network, the fibrous proteins embedded within provide the structural and functional cues for 
cells [14,15]. 
 
2.3.2 Glycosaminoglycans 
 
GAGs are long, unbranched, mostly high molecular weight polysaccharides (also 
mucopolysaccharides) with a backbone of repeating disaccharide units incorporating an 
aminosugar and an uronic acid. There are two main types of GAGs, heparan sulphate and 
chondroitin sulphate. Proteoglycans occur when one or more GAGs are attached to a core 
protein at specific sites. Proteoglycans are found throughout the extracellular matrix and 
attached to the cell membrane. Chondroitin sulphate chains are mostly found on matrix 
proteoglycans (aggrecan) whereas membrane proteoglycans contain mostly heparan sulphate 
chains (syndecan, glypican) [16]. Proteoglycans form a gel-like ground substance of the 
connective tissue and fill most of the extracellular space because of their hydrophilic nature. 
Other functions are to interact with signaling molecules, to modulate ligand-receptor 
interactions, and to play a role in development, migration, and enzyme activity. Proteoglycans 
are furthermore involved in several signaling pathways like TGFß, FGF, Hedgehog, etc. 
Additionally, proteoglycans form networks by linking to collagen fibers [17]. 
 
2.3.3 Collagens 
 
Collagens represent the most abundant fibrous proteins in vertebrates, constituting 30 percent 
of the total body protein. To date, 28 types of collagen have been identified and described with 
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the five most common types of collagens being collagen I (skin, tendon, vascular ligature, 
organs, bone), collagen II (main component of cartilage), collagen III (main component of 
reticular fibers, commonly found alongside collagen I), collagen IV (basal lamina) and 
collagen V (cell surfaces, hair and placenta) [18]. 
Ubiquitously expressed in all mammals, type I collagen is the most abundant type, constituting 
more than 90 percent of all collagens. It is one of the largest and most complex 
macromolecules. Some of the proposed functions of collagen I include mediation of cell 
adhesion, binding to other matrix molecules, interactions with tissue calcification factors, but 
also glycation. Glycation occurs when reducing sugars bind to protein, forming adducts. Those 
glycation products are believed to contribute to diabetes development and pathologies of aging 
[19]. 
 
2.3.4 Fibronectin 
 
Another essential ECM molecule is the ubiquitously cell-mediated expressed glycoprotein 
fibronectin (FN), found in blood as soluble FN and in interstitial connective tissue as insoluble 
FN [20]. The dimeric protein, consisting of two nearly identical monomers linked by a pair of 
disulfide bonds, is organized into a fibrillar network through direct interactions with cell 
surface receptors called integrins [20–22]. FN plays a pivotal role during embryogenesis, 
guiding cell migration and adhesion. Being part of the ECM network, FN is essential for cell 
growth, attachment, migration, and development [21]. As soluble FN, it is also very important 
in wound healing, contributing to the initial blood clot formed at the site of injury together 
with fibrin [23]. FN can bind and interact with other ECM components, such as collagens and 
proteoglycans, especially heparin, and fibrin. Within the cell-binding domain of FN a specific 
adhesion sequence called RGD is found [24]. RGD is a tripeptide composed of L-arginine, 
glycine, and L-aspartic acid (Arg-Gly-Asp). This sequence constitutes the best known 
integrin-binding region in FN. Other integrin-binding minimal sequences can be found in the 
cell-binding domain of FN such as LDV (Leu-Asp-Val), REDV (Arg-Glu-Asp-Val), IDAPS 
(Ile-Asp-Ala-Pro-Ser) and KLDAPT (Lys-Leu-Asp-Ala-Pro-Thr). Those binding sites 
recognize the α4β1 integrin and α4β7 integrin (except for IDAPS). 
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2.3.5 Integrins 
 
Integrins are a family of 24 identified trans-membrane receptors, mediating cell adhesion to 
the ECM, activating intracellular signaling pathways, and supporting cell-cell contacts [25]. 
Integrins are heterodimers, composed of two distinct polypeptide chains, called α and β 
subunits. To date, 18 α and 8 β subunits have been identified. Both subunits breach the cell 
membrane, with the major part being in the extracellular space and a minor domain in the 
cytoplasm [25,26]. Integrin receptors bind to and interact with several ligands such as 
collagen, RGD, leukocytes, and laminin.  
Some α subunits can only bind to one specific β subunit e.g., α5 with β1 or α1 with β1, 
whereas others can bind to several β subunits e.g., αV with β1, 3, 5, 6, or 8  [25]. Integrins are 
known for their ability of bidirectional signalling. “Outside-in” is conceived through binding 
of extracellular ligands found in the ECM or to integrins on the cell surface, leading to the 
initiation of intracellular signalling pathways associated with cytoskeleton proteins. “Inside-
out” signalling is achieved by a reciprocal interaction of integrins with the extracellular 
domains. This occurs after cells have received signals through other surface receptors. These 
signals are then translated by integrins to enhance adhesiveness and migration [25]. 
 
2.3.6 Laminins 
 
Laminins are a family of major proteins in the basal lamina of the basement membrane. They 
are cross-shaped heterotrimers, composed of one α, one β and one γ chain [27]. As 
glycoproteins in the BM, laminins function as structural support for cells, promote cell 
adhesion, migration, differentiation, and morphology, and prevent cell death via anoikis. 
Anoikis is a special form of apoptosis, the programmed cell death, caused by detachment or 
loss of anchorage of cells from their ECM [28]. Laminins exhibit their actions through various 
cell receptors such as integrins [29] but also through non-integrin receptors such as the 67kDa 
laminin receptor [30,31]. 
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2.3.7 Fibrin as a Transient Component of the ECM 
 
Additionally to collagens, laminins, proteoglycans, and FN, fibrin can be considered being 
part of the ECM as cells interact with fibrin through integrin receptors. Fibrin is naturally 
formed from fibrinogen, a soluble liver-derived protein found in blood plasma, when tissue 
damage results in bleeding [32]. Thrombin, a clotting enzyme, converts circulating fibrinogen 
into fibrin at the site of injury [33,34]. Fibrin molecules are arranged in long fibrous chains 
[35] which are combined to form thread which trap platelets within, forming a spongeous clot 
to stop the bleeding. The fibrin mesh provides anchorage sites for platelets, fibroblasts, 
neutrophils and monocytes supporting wound healing in the process [36–38]. While the clot in 
the vessel helps to re-establish normal blood flow, part of the clot in the injured tissue 
provides a transient ECM for cell migration and tissue reformation. 
In vitro biodegradable fibrin gels are quite similar to in vivo fibrin clots [34,39]. In the context 
of biomaterials for tissue engineering and cell encapsulation in transplantation, fibrin matrices 
can provide structural support for cells and cues from the ECM [32,37,40]. Fibrin has been 
already widely used in clinical applications. In the context of pancreatic islet transplantation, 
fibrin has shown potential for improving islet viability, function, and preservation of native 
islet morphology [40–45]. Another advantage of the usage of fibrin matrices in transplantation 
medicine could be the possibility to use the graft recipient’s blood fibrinogen to obtain a fibrin 
scaffold which would probably lower the intensity of the initial immune response to the 
transplant. However, in vivo fibrin clots undergo fibrinolysis eventually in the course of an 
inflammatory and wound healing setting, consequently, impairing the feasibility of fibrin as 
sole component to constitute a device to encapsulate islets for transplantation purpose [46,47]. 
 
2.3.8 ECM of the Human Endocrine Pancreatic Islets 
 
The structure and composition of the native ECM of islets are still under investigation. Islets 
are among the most vascularized structures in the human body. Communication between islet 
cells and the endothelial cells is achieved through their common vascular basement 
membrane. Islets have a second basement membrane of unknown origin [48,49]. FN, RGD, 
and laminins have been studied widely; the interactions between endocrine pancreatic islets  
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and FN, RGD, and laminins have been investigated with the aim to enhance islet survival and 
function as well as insulin secretion [50–53]. Certain integrins have been found to be 
expressed within the islet and by beta cells. Integrin β1 appears to be the most prominent islet 
integrin and has been widely studied in terms of islet cell adhesion, proliferation, 
differentiation, and survival [53–55]. The islet basement membrane contains various ECM 
proteins such as laminins and collagens, providing binding and interaction sites with (β1) 
integrins [48,56]. In vitro, a matrix enriched with laminin enabled α6β1 integrin-mediated beta 
cell spreading, decreased apoptosis and improved insulin secretion [52,53,57]. FN, RGD, and 
the laminin peptide YIGSR, covalently bound to low-fouling carboxymethyldextran, improved 
INS-1 (rat insulinoma) cell proliferation, integrin expression, and glucose-stimulated insulin 
secretion [58]. As those beneficial ECM cues are absent during islet transplantation, due to the 
islet isolation procedure, provision of a ECM-enriched encapsulation matrix such as fibrin or 
alginate could constitute a valuable protection from the immune response to an allogenic or 
xenogenic islet graft [9,59–62]. 
 
2.4 The Immune System 
 
The complex immune system has developed to protect the human body from various 
pathogens such as parasites, viruses and bacteria. Its complexity is becoming clear when 
regarding the cells and soluble mediators involved in the immune response and the fact that, 
besides an innate immune system, an adaptive immune system evolved in the human body. 
 
2.4.1 Innate and Adaptive Immune Systems 
 
The immune system in its entity is comprised of two distinct types of immune responses, the 
innate and the adaptive immune responses, each functioning apart from each other but 
interacting with each other intensely. The main difference between the innate and the adaptive 
immune response is the respective speed of the immune response and its specificity towards 
the pathogen resulting in immunological memory by the adaptive immune response [63–65]. 
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The innate immune system has been highly conserved. A fast but unspecific immediate 
defence reaction is provided without any memory by elements like neutrophils, monocytes, 
macrophages, natural killer cells, complement, cytokines, and acute phase proteins but also 
through physical, chemical, and microbiological barriers. Sometimes, the unspecific response 
of the innate immune system can cause tissue damage via an uncontrolled inflammatory 
reaction  [64,66]. In contrast, the response of the adaptive immune system is exhibited through 
antigen-specific T and B lymphocytes and may take days or even weeks to develop. After 
successful immune response to a foreign antigen, the adaptive immune system produces long 
lasting memory cells [64,65]. 
 
2.4.2 Immune Cells 
 
Leucocytes (“white blood cells”) are the cells without whom any immune response would not 
be possible. They are divided into lymphocytes, phagocytes and auxiliary cells but normal 
tissue cells also contribute to the immune response by expressing foreign DNA fragments on 
their surface, thus signalling to lymphocytes. In addition, normal tissue cells respond to 
secreted cytokines, and even secret certain cytokines themselves. Lymphocytes are subdivided 
into B cells, T cells, and large granular lymphocytes, namely natural killer cells (NK). 
Phagocytes are neutrophils, eosinophils, and mononuclear phagocytes. Basophils, mast cells 
and platelets are part of the auxiliary cell compartment [63]. 
 
2.4.2.1 Neutrophils 
 
Neutrophils are central in the innate immune system’s response as they are the first to arrive at 
the site of aggression. They are recruited and activated by cytokines released from activated 
macrophages at the site of tissue injury or inflammation, namely granulocyte- and 
granulocyte-macrophage-colony stimulating factors (Figure 2.1). Bone-marrow derived 
neutrophils circulate in the blood and follow a cascade of pro-inflammatory mediators, 
adhesion molecules, and chemokines to reach a site of infection [67]. On site, neutrophils 
phagocytize pathogens and then kill the organism through the release of reactive oxygen 
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species and highly toxic cationic proteins and enzymes. If pathogenic organisms are coated 
(opsonized) first with specific antibodies or complement, the neutrophils ability to ingest and 
destroy those pathogens, is highly elevated [63]. 
The complement system is a complex entity of proteins and glycoproteins, mainly produced in 
the liver, circulating in blood as pro-proteins. Among the several functions of the complement 
system are opsonisation, cell lysis, and chemotaxis. Once activated, the complement system 
amplifies the immune response, both innate and adaptive, and therefore, is an important 
mechanism for removing a foreign organism from the host [68,69]. 
 
2.4.2.2 Granulocytes: Eosinophils, Basophils and Mast cells 
 
Eosinophils main function is the removal of parasites via binding to the antibody-coated 
organism. Eosinophils destroy the parasite by releasing cytotoxins onto the parasite’s cell 
surface [63,70]. They are involved in the removal of fibrin in inflammation and play a role in 
asthma and allergy control. 
Basophils circulate in blood and are involved in allergic reactions [71]. They are thought to 
contribute to the severity of these reactions acting as pro-inflammatory effector cell. Since 
basophils express major histocompatibility complex  (MHC) proteins, class II, they are 
potentially antigen-presenting cells (APC) and could act in T cell activation and regulation 
[72]. 
Mast cells are quite similar to basophils as both cell types contain basophilic granules. As 
opposed to basophils, which mature in the bone marrow and are then released into the blood 
stream, mast cells are released from bone marrow immaturely and mature later in the tissue 
where they reside. Mast cells, not unlike basophils, are involved in anaphylactic and other 
allergic reactions. They also play a role in wound healing and pathogen defence [73]. Mast 
cells, as well as basophils, have granules which contain the vasodilator histamine and the 
anticoagulant heparin. The granules can also contain various effector molecules such as serine 
proteases and serotonin. Recent evidence suggests that mast cells play a role in the onset and 
progression of T1DM [74]. 
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2.4.2.3 Natural Killer Cells 
 
NK cells share the same lineage as T and B lymphocytes but are part of the innate immune 
system and they should not be mistaken with natural killer T cells. NK cells are essential for 
the innate immune response as they act fast and recognize cells in distress i.e., infected cells or 
cancer cells, even in the absence of antibodies or MHC expressed on the cell surface 
[66,75,76]. In fact, the absence of MHC proteins could trigger recognition by NK cells and 
direct cell susceptibility to be lysed [77]. Besides their cytotoxic functions, NK cells secrete a 
wide variety of cytokines, especially interferon gamma (IFNγ), of which they are recognized 
to be the main producer [78,79]. 
 
2.4.2.4 Dendritic Cells 
 
Antigen-presenting cells (APC) link the adaptive immune response of B and T cells with the 
innate immune response. Dendritic cells (DC), macrophages, certain B lymphocytes, and 
activated epithelial cells comprise the pool of professional APC alongside with unprofessional 
APC, such as Langerhans beta cells, fibroblasts, glial cells etc.  
DCs primary function is to internalize and present antigens through their dense levels of MHC 
proteins on their surface. Even though B lymphocytes present antigen on their surface as well, 
DC activate and regulate both B and T lymphocytes. DC are the only cells known to be able to 
activate resting naïve T cells [80]. 
 
2.4.2.5 Monocytes and Macrophages 
 
Bone marrow-derived monocytes are the largest leukocytes which are released into blood 
circulation after maturation and differentiate into macrophages upon tissue infiltration [81]. 
Monocytes were once characterized by strong expression of CD14, a surface receptor 
interacting with the toll-like receptor in the recognition of bacterial lipopolysaccharides (LPS). 
Now it is known that some subpopulations of monocytes have differential expression profiles 
of CD14 and CD16, such as CD14++/CD16- (classical monocytes), CD14+/CD16++ (non-
classical monocytes), and CD14++/CD16+ (intermediate monocytes), resulting in different 
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functions [81–83]. For example, non-classical monocytes secrete more pro-inflammatory 
cytokines upon activation. Amongst the multiple functions of monocytes is the provision of 
myeloid precursor cells for the replenishment of tissue macrophages and DC. Although large 
numbers of monocytes are residing in the spleen, blood-circulating monocytes can reach a site 
of injury or inflammation within 8 to 12 hours. When entering the tissue, monocytes 
differentiate into macrophages or DC. Macrophages exist in two forms, M1 and M2. M1 
macrophages, the “killer” phenotype, are the classically activated macrophages. M1 express 
inducible nitric oxide synthase (iNOS) and a multitude of pro-inflammatory cytokines, such as 
TNFα, IL-1β, IL-6, etc. [84]. M2, on the contrary, function in a more regulatory manner, 
removing debris and promoting tissue repair. By secreting IL-10 and TGFβ1, M2 
macrophages contribute to the regulation of the immune response to prevent an overreaction 
[85]. As APC, macrophages internalize pathogens, digest them and then present antigens 
linked to MHC proteins on their surface which consequently activates T lymphocytes [63]. 
 
2.4.2.6 T Lymphocytes 
 
T cells are part of the adaptive immune system [63]. T cells are distinguished from other 
lymphocytes by the T cell receptor expressed on their surface [86]. As B cells, T cells 
originate from the bone marrow but mature in the thymus gland, hence their name. T cells are 
not antigen-presenting immune cells but require APC such as monocytes/macrophages, 
dendritic cells (DC) and also B cells or natural killer cells for activation [87]. There are 
multiple subsets of T cells: helper T cells (TH), cytotoxic T cells (TC), memory T cells, natural 
killer T cells, and regulatory T cells (Treg) [63].  
T cells recognize antigens which are associated with so called major histocompatibility 
complex (MHC) proteins on the cell surface of APC [86,88,89]. TH cells recognize MHC class 
II associated antigens with their CD4 receptor whereas TC cells are activated by MHC class I 
associated antigens which are recognized by their CD8 receptor [88,90]. Treg cells suppress T 
cell activity towards the end of an immune response and help identifying and cleaning auto-
reactive T cells, which escape negative selection in the thymus, from the system. Memory T 
cells are comparable in their function to B cell-derived memory cells and can be either CD4+ 
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or CD8+. Natural killer T cells, other than TH and TC, recognize glycolipid antigens presented 
by CD1d. Upon activation, natural killer T cells can function as TH or TC [63,91].  
In T1DM, T cells were previously believed to be the main acting immune cell, mediating 
pancreatic beta cell death through recognition of self-beta cell-antigens as foreign, probably 
following an initial viral infection. Another theory suggested that the viral antigen resembled 
the beta cell antigen, thus, inducing an immune response to beta cells. Several facts contradict 
the supposed T cell-mediated beta cell destruction, as the course of the disease is a slow 
process over years whereas a T cell immune response is very specific and effective, lasting for 
several days or weeks only [92]. 
 
2.4.2.7 B Lymphocytes 
 
B cells are considered being effector cells of the humoral arm of the adaptive immune 
response [63]. B cells are antigen-specific antibody-producing lymphocytes, expressing a 
specific B cell receptor on their surface. This receptor, comprised of immunoglobulins, only 
recognizes one specific antigen [91]. Produced in the bone marrow, mature B cells circulate in 
the blood system until activation through antigen recognition and an additional T cell signal 
[93]. B cells will then differentiate into either B memory cells or plasma B cells. The 
immunoglobulin (antibody) which recognizes the foreign antigen is released abundantly by 
plasma cells, whilst memory cells are responsible for the subsequent recognition of the same 
antigen in case of repeated exposure, ensuring facilitated clearance [94]. 
B cells play a role in the development of T1DM autoimmunity. Islet-autoantibodies to insulin, 
glutamic acid decarboxylase, tyrosine phosphatase IA-2, etc. found in T1DM patients or even 
before the onset of T1DM indicate that B cells recognized, bound and internalized islet 
antigens and produced antibodies in response [95].  
 
2.4.2.8 Cytokines 
 
Cytokines serve a multitude of purposes and show a great variety in their size, structure and 
function, and they are synthesized by almost every cell in the body. They are considered to be 
a group of soluble proteins, glycoproteins and peptides, secreted in response to a trigger i.e., a 
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stress signal. Cells secrete cytokines to either change their own behaviour or influence other 
cells. Cytokines interact with cell-surface receptors and induce cytokine-specific intracellular 
pathways [91]. Cytokines can exhibit pro- and anti-inflammatory characteristics of sometimes 
contradicting nature [96]. For example, interleukins (IL)-10 are known to activate B 
lymphocytes but they are anti-inflammatory cytokines as they act in the impairment of pro-
inflammatory cytokine expression [97].  In the context of T1DM, TNFα, IL-1β, IFNγ, and IL-
6 are the most prominent pro-inflammatory cytokines contributing to beta cell apoptosis, B- 
and T- lymphocyte activation, and excessive autoimmune reaction [98]. 
 
2.4.3 Type 1 Diabetes Mellitus 
 
Type 1 diabetes mellitus (T1DM) is an auto-immune disease defined by the loss of 
endogenous insulin due to the destruction of insulin-producing β cells by the immune system 
[99]. Autoimmunity occurs when immune cells recognize self-antigens as foreign antigens and 
start reacting to them. In T1DM, autoimmunity is most probably based on a combination of 
genetic susceptibility and its clinical expression through the influence of various 
environmental factors such as viruses, toxins, stress, and diet [100–103]. Islet auto-antigens 
are presented by APC to helper T cells (Th cells) associated with major histocompatibility 
complex (MHC) class II molecules [104]. In the thymus, T cells are matured and selected for 
their reactivity. Normally, T cells reacting to self-antigens undergo negative selection and are 
destroyed [63]. T1DM develops over the course of several months up to several years and is 
the product of an immune reaction cascade leading to beta cell destruction. It is now believed 
that T cells are not the main effector immune cells in T1DM as their misled response to islet- 
or beta cell-auto-antigens would lead to a specific and efficient, relatively fast removal of all 
cells expressing these antigens [92]. Nonetheless, T cells must play a role in T1DM as islet-
auto-antibodies produced by T cell activating B cells are found before T1DM onset and in 
patients. These auto-antibodies contribute to the development of autoimmunity and exacerbate 
the ongoing immune response [105]. 
The T cell-mediated beta cell destruction occurs after CD4+ T cell activation via APC-derived 
IL-12. This leads to an imbalance of regulatory and effector immune cells. In turn, CD4+ T 
cells activate CD8+ cytotoxic T cells through IL-2 secretion. IFNγ, produced by CD4+ T cells, 
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activates cytotoxic macrophages which secrete pro-inflammatory TNFα, IL-1β, and IFNγ, as 
well as reactive oxygen species i.e., O2*, H2O2, and NO [98,106]. 
Cytotoxic T cells, in response to antigen presentation, migrate towards the source i.e., the 
islets, and start secreting apoptotic and pro-inflammatory cytokines. Additionally, cytotoxic T 
cells can induce islet cell apoptosis via the Fas ligand pathway [107,108]. Interplay of T cell 
activation, antigen presentation, antibody secretion and circulation, formation of memory 
cells, further immune cell recruitment, and the development of auto-immunity, consequently 
result in the onset of T1DM when more than 90 percent of beta cells have been killed and have 
lost their functionality. 
 
2.4.4 Islet Transplantation 
 
Islet transplantation research aims to improve the outcomes and longevity of the islet graft to 
eventually provide a long-term treatment of T1DM patients or even a cure of this life 
threatening disease [4]. The basic idea of islet transplantation as opposed to whole pancreas 
transplantation is the circumstance of insulin deprivation in the patient which could be 
restored by just transplanting the functional unit of insulin production, the pancreatic islets [8]. 
A whole pancreas transplant comes with the limitations of organ donors, major surgery 
complications, life-long immune suppression and the sustenance of diabetes-related secondary 
complications. In contrast, islet transplantation is performed through injection of a suspension 
of isolated islets in the portal vein with lower risks associated with the surgery. Co-
transplantation with a kidney transplant is also administered. But the success of islet 
transplantation is impaired by the requirement of multiple donor organs for a sufficient islet 
graft, graft loss due to immune rejection and the immediate blood-mediated immune response, 
damages to islets caused by isolation procedures, lack of efficient re-vascularisation, as well as 
loss of function over time [109–111]. 
The introduction of the Edmonton’s protocol resulted in improved islet isolation procedures, 
islet yield, transplantation, immune suppressive treatments, and consequently with an 
improved success rate [112]. In spite of this, the majority of patients reverse from temporary 
insulin independence to exogenously applied insulin [113]. 
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Multiple factors are responsible for the loss of islets and the loss of function of the islet graft. 
In the context of this review, the most prominent reason is the rejection of the graft by the 
recipient’s immune system in combination with loss or damage of the native islet ECM. 
Recent studies have shown that the islets ECM, and more specifically, cell-integrin 
interactions, mediate apoptosis resistance and support viability and function of pancreatic beta 
cells. Over the years, various islet encapsulation attempts using (bio)materials have been made 
to either protect the islets from immune cell invasion or to provide ECM cues for better 
engraftment [9,59–61,114]. 
But how does the ECM actually interact with the immune system and are those interactions 
beneficial or detrimental for an islet graft are questions that are not completely elucidated. 
 
2.5 Interactions between the ECM and the Immune System 
 
The ECM is essential for immune system response in various aspects. Here, the role and 
function of leukocyte integrins will be discussed as well as the interactions between the ECM 
and cytokines. Furthermore, the involvement of the ECM in wound healing and islet 
transplantation will be investigated. 
 
2.5.1 Integrins of Immune Cells 
 
ECM-immune cell interactions play a pivotal role in immune cell development and function. 
Integrins are the main adhesion receptors for those interactions. Of the 24 integrins known to 
date, 13 are expressed by leukocytes, but only β2 and β7 integrins are exclusively expressed 
by leukocytes [115,116]. Integrin β2 plays an especially important role in leukocyte biology. 
Of β2, four αβ heterodimers exist, namely leukocyte function-associated antigen 1 (LFA-1; 
CD11a/CD18, αLβ2 integrin, ITAL antigen), Mac-1 (CD11b/CD18, αMβ2 integrin, ITAM 
antigen), p150,95 (CD11c/CD18, αXβ2 integrin, CR4, ITAX antigen), and αdβ2 (CD11d/ 
CD18, ITAD antigen) [117]. Of the β1 integrins, pairings with α1, 2, 3, 4, 5 and 6 are found in 
leukocytes. Integrins α4β7 and αEβ7 are found to be expressed on leukocytes. Integrin β2 is 
the only integrin found to be expressed on all leukocytes. Apart from integrin β2, the integrin 
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expression profile differs between the different immune cells. Integrins β1, 2 and 7 are 
variably expressed by T lymphocytes e.g., integrins α4β7 and α4β1 are expressed in immature 
and activated T cells [118]. The integrin expression of T lymphocytes depends on the T cell 
subtype and the state of inflammation [119]. Monocytes express β1 and β2 integrins but also 
express αVβ3 after differentiation into macrophages [120–123]. Granulocytes (neutrophils, 
eosinophils, basophils and mast cells) express β1, 2 and 3 heterodimers for migration and 
motility in tissues [124–128]. 
Leukocyte integrins are inactive during a non-inflammatory state and are only activated when 
membrane receptors involved in an immune response are stimulated. In a healthy individual, 
leukocytes are circulating in the blood and need integrins to attach to blood vessel walls and 
migrate into inflamed tissues or lymph nodes. When chemokine-, B cells- or T cell- receptors 
bind to antigens, cytokines, chemokines, etc., the inside-out signalling of integrins on 
leukocytes is activated. For leukocytes to migrate to the site of inflammation or into lymph 
nodes, binding to endothelial cells is of great importance for initiating the adhesion and 
migration cascade. Selectins allow the leukocytes to bind weakly to endothelial cells. The 
stimulation with chemokines or chemotactic molecules activates leukocyte integrins which are 
then able to engage with counter-receptors of endothelial cells. Both β1- and β2-integrins are 
activated by signals that are elicited by chemokines [129]. 
With the blood circulating in the vessels, creating shear flow on cells, cell binding to 
endothelium has to occur in a step-by-step process. Leukocytes that interact with endothelial 
cells first roll along the vessel walls. This first weak adhesion step is supported by L-selectin 
and α4 integrins [130–133]. During the rolling step, chemokine-induced activation of 
leukocyte integrins follows to allow firm adhesion [132].  
The sources of the chemokines responsible for activating leukocyte integrins are endothelial 
cells, leukocytes or stromal cells. ECM proteins are known to be capable of binding and 
storing cytokines and chemokines [134]. Transmembrane proteoglycans i.e., heparan 
sulphates, on the luminal surface of endothelial cells can bind some chemokines, such as CC-
chemokine ligand 5 (CCL5; also known as regulated upon activation, normal T-cell expressed 
and secreted, RANTES) and CXC-chemokine ligand 8 (CXCL8; also known as interleukin-8, 
IL-8) [135,136]. The main heparan sulphates binding chemokines are syndecan 1 and 
syndecan 4 (which bind CCL5) and syndecan 2 (which interacts with CXCL8)  [135–137]. To 
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be able to activate leukocyte integrins, the chemokine receptor binding site of the chemokines 
remains available even when bound to proteoglycans [138]. The stimulation of the leukocytes 
with those membrane-bound chemokines leads to firm adhesion to the endothelium [119,132]. 
Together with integrin α4β1, integrin αLβ (LFA-1) is one of the most important leukocyte 
integrins contributing to leukocyte-endothelium adherence [139,140]. Arrest of leukocytes on 
the vessel wall is followed by their migration through the endothelium and underlying 
basement membrane. This process is also called diapedesis, transmigration or extravasation 
[141]. It was shown that LFA-1 and integrin α4β1 are the mediators of leukocyte migration 
depending on chemokine activation and ligand expression [142,143]. Interestingly, in the case 
of monocytes, binding to FN at the site of inflammation is necessary for their differentiation 
into tissue macrophages [144,145]. After extravasation, ECM molecules serve as an anchor for 
immune cell migration [146].  
T lymphocytes migrate into lymph nodes where they are regularly exposed to APC to be 
possibly activated by foreign antigens. It is of great importance to spend sufficient time in the 
lymph nodes to establish a stable bond with APC through integrin interactions to ensure 
appropriate delivery of antigens to T lymphocytes for their activation and consequent immune 
response [147]. 
Integrins have been shown to accumulate on one part of the cell to increase local adhesiveness 
and avidity. This occurs on T lymphocytes, especially for integrin LFA-1, when T cells are 
activated with antigens. LFA-1 accumulation on the binding site of T cells with APC results in 
enhanced ligand binding and, therefore, facilitates antigen presentation and T cell activation 
[148]. LFA-1 is also rearranged with the TCR and other T cell receptors to form a so-called 
immunological synapse (supramolecular activation cluster). Even though questions about the 
exact function of this synapse remain, it is believed that it supports cytotoxic granule release 
by T lymphocytes or NK cells [149–151]. In addition, integrin signalling in T cells supports T 
cell activation, proliferation and cytokine secretion [152–154]. In macrophages, integrin 
activation supports phagocytic activity, cell differentiation and also cytokine secretion 
[155,156]. In neutrophils, degranulation and release of ROS through NADPH oxidase 
activation is facilitated through integrin signalling [157]. 
It is clear that integrins play an integral role in leukocyte migration, function and interaction 
with cells and tissues [156,158]. They also contribute to leukocyte development and 
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maturation in the bone marrow and thymus gland [159]. As an example, B cell development 
needs a defined microenvironment to mature. This development is controlled through an 
interaction of integrin α4β1 with FN and stromal cells of the connective tissue, expressing the 
vascular cell adhesion molecule (VCAM)-1 [160–162]. 
 
2.5.2 The ECM and Cytokines 
 
The ECM directly influences cell proliferation, differentiation, migration, and apoptosis 
through interaction via integrins [11] and non-integrin cell receptors [163]. The structure of 
the ECM and its composition vary greatly between different kinds of tissues, resulting in 
matrices of specific properties tailored to the embedded cells [11]. Activation of integrin 
receptors through ECM binding leads to induction of intracellular signalling pathways and 
alterations in gene expression, therefore, ECM directly influences cell behaviour. Soluble 
mediators, namely cytokines, growth factors and chemokines also affect cell behaviour. 
Apart from their functions in stimulating immune cells and increasing effective immune 
response, cytokines exhibit effects on adhesion through augmentation of the adhesiveness of 
endothelial cells [164]. Macrophage-derived TNFα [165] and IL-1β [166], as well as 
lymphocytic IFNγ [167], were found to be among the soluble mediators of this interaction 
between cytokines and endothelial cells. The ECM can bind and store certain cytokines, 
making them available for later use and concentrating them at their area of effect [168]. TNFα, 
bound to FN or laminin, was found to improve the adhesion of T lymphocytes to FN or 
laminin via an integrin β1-dependent interaction [169,170]. 
TNFα is one of the inflammatory cytokines influencing matrix metalloproteinase proteins 
(MMP) expression by immune cells, thus, playing a role in tissue remodelling. MMPs are part 
of a family of zinc-dependent endopeptidases involved in the degradation, turnover and 
remodelling of multiple ECM proteins. They contribute to wound healing, immune cell 
invasion, and embryonic development [171]. Together with IL-4 and IL-1β, TNFα enhances 
MMP expression and activity to reach the site of tissue injury and remodels the tissue at the 
site of inflammation [171,172]. When monocytes migrate into tissues, their differentiation into 
macrophages is induced by ECM and cytokine interactions [144,145]. During this FN-
adhesion-dependent differentiation, MMP-9 (gelatinase B) expression is induced [173] 
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causing a TNFα-dependent increase in α5β1 integrin expression [174]. In return, TNFα was 
shown to be capable of inducing MMP-9 expression in human monocytes [175] and 
monocyte-derived macrophages [176]. 
More functional interactions between cytokines and ECM proteins are postulated. Certain 
cytokines like the basic fibroblast growth factor (bFGF) depend on ECM binding to exhibit 
their full function [177]. It has been shown that bFGF binding to heparan sulfate 
proteoglycans is pivotal for bFGF binding to its high affinity cell receptor [178]. Similar 
relationships for other cytokines requiring binding to ECM molecules, as co-receptors, are 
likely. 
Emerging research shows an implication of ECM-derived peptides, emerged either after 
cleavage of ECM proteins or as a product of tissue injury, in immune system responses, acting 
as chemoattractants or mediating cytokine synthesis [179]. These so-called matrikines and 
their interaction with immune cells have been reviewed elsewhere [180]. 
 
 
Figure 2.1: Schematic presentation of leukocytes recruitment to the site of inflammation (left) 
and immune cell response in tissue injury (right). CXCL-8 is the receptor for IL-8. LFA-1 
(leukocyte function-associated antigen is the αLβ2 leukocyte integrin. VCAM-1 (vascular cell 
adhesion molecule). MMP (matrix metalloproteinase proteins). Not drawn to scale. 
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2.5.3 Implications of ECM-Mediated Immune Response in Wound Healing 
in the Context of Islet Transplantation 
 
Since currently the most common method of administering an islet graft is direct injection into 
the portal vein, the foreign tissue is exposed directly to the venous blood and all its 
components, triggering a so-called instant blood-mediated inflammatory reaction (IBMIR) 
[181] (Figure 2.2). Inactive leukocytes circulating in the blood encounter allograft antigens, 
which triggers their activation and consequent immune response. In addition, the injection 
causes tissue and vessel injury initiating a wound healing cascade [182] characterized by rapid 
infiltration of neutrophils to the site of injury, followed by monocytes, differentiating to 
macrophages on site, and later lymphocytes [183]. Wound healing is understood to be 
constituted of overlapping steps of hemostasis, inflammation, proliferation, and remodelling. 
Each step involves the ECM, cytokines and cells [184] . As described above, heparan sulfate 
proteoglycan-bounded bFGF is released during protease-directed ECM cleavage and induces 
endothelial cell and fibroblast growth [185]. Immune cells secrete cytokines in response to 
tissue injury to trigger proliferation of endothelial cells, fibroblasts, and smooth muscle cells 
[186]. ECM fragments, mentioned above as matrikines, especially FN-derived ECM 
sequences, attract monocytes which then differentiate into tissue macrophages through binding 
to FN [144,145,187]. Phagocytic activity is increased and leads to further ECM cleavage and 
debris removal, and the stimulation of growth factor expression and secretion to affect the 
synthesis of ECM proteins by surrounding cells [188,189]. Wound healing is a very complex 
process and each year, new cytokines, interactions and mechanisms are revealed (reviewed in 
[190]). 
Another aspect of wound healing lies in the clotting of blood initiated through injury and 
consequent bleeding. Fibrin clots are very important in wound healing, providing anchorage 
for platelets, fibroblasts, neutrophils and monocytes [37,38]. Fibrin is the product of 
fibrinogen molecules polymerizing into a cross-linked network after thrombin activation [34]. 
Fibrinogen is classically synthesized in the liver and its production is regulated by several 
inflammatory cytokines e.g., IL-1β and IL-6 [191]. Consequently, fibrinogen synthesis is up-
regulated during inflammation. The initial fibrin clot is meant to inhibit bleeding to reduce 
further blood loss. Almost instantly, the fibrin network is invaded by leukocytes, as well as by 
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platelets and fibroblasts. Leukocytes, and other cells, bind to fibrin via their integrins and 
other non-integrin receptors such as cadherins. Phagocytes are among the first leukocytes to 
enter the fibrin clot. Through integrin interactions with the fibrin mesh, leukocyte activity, in 
terms of extravasation and migration, is regulated, indicating a direct involvement of fibrin in 
the immune response [192]. In addition, fibrin, similar to conservative ECM proteins, can bind 
growth factors e.g., bFGF and vascular endothelial growth factor, and through that can direct 
cell growth and remodelling of tissues [193]. Fibrinolysis occurs to prevent an excessive 
growth of the fibrin clot at the end of the wound healing process through activation of 
plasminogen into plasmin, a serine protease. Slowly released endothelial tissue plasminogen 
activator (tPA) is the main source of fibrinolytic activity. Macrophages were shown to 
contribute to fibrinolysis through a membrane-bound PA which functions relatively unaffected 
by soluble protease inhibitors [46].  
IBMIR is most probably contributing to the destruction of the islet graft by the recipient’s 
immune system as a platelet-mediated clot is formed around the transplant, enhancing the 
immune cell response as described above. Several approaches in islet transplantation research 
to protect the graft from the immune system have been taken including different 
transplantation sites [8], various immune suppressive regimes [194], suppression of MMP 
activity [195], and more recently encapsulation attempts.  
The concept of islet encapsulation is based on the assumption that the islet graft could be 
physically shielded from invading immune cells and antigen detection. Since it has been 
shown that isolated human islets are capable of producing and secreting monocyte 
chemoattractant protein-1 (MCP-1) themselves, the development of a protective barrier seems 
even more important [196]. Fibrin gels are among the materials in discussion for islet 
encapsulation as their clinical compatibility has been confirmed [32,37,40]. In terms of islet 
transplantation, fibrin as a transient ECM provides structural support as well as improved 
viability and islet function based on the fibrin-integrin interactions [40,41,43–45,197]. 
Another advantage of fibrin as encapsulation material could be the possible use of the 
recipient’s fibrinogen as a source for the islet graft scaffold. This could lead to a delayed 
immune reaction to the graft. 
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Figure 2.2: Schematic presentation of the immune response during islet grafting (left), instant 
blood-mediated inflammatory reaction (IBMIR) and islet encapsulation (right). MCP-1 
(monocyte chemoattractant protein-1). Not drawn to scale. 
 
2.6 Conclusions 
 
In this review, we tried to give a basic summary on ECM molecules, the immune system and 
the emerging research on their interactions. The immune system was thought to mainly act and 
respond on its own but it is now evident that not only interaction with other cells but also 
interaction with the surrounding ECM controls, stimulates and influences the immune 
response in various ways which are not yet entirely understood. New information is revealed 
continuously and we believe that, in the context of T1DM and islet transplantation, this 
information may be used in the future to elaborate concepts of islet encapsulation and immune 
specific regulation as shown by Lingwal et al. [195]. Caution should remain in terms of 
immune suppression. Apart from complications like kidney damage and deterioration of 
insulin secretion [198,199], suppression of the immune system is always dangerous for the 
patient as its response to a pathogen invasion is less efficient. Finally, ECM cues and fibrin 
carrier systems for pancreatic islets have proven to be beneficial for islet survival, function 
and maintenance of the graft. As discussed in this review paper, ECM supports immune cells 
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in their function, proliferation and development which could be an actual disadvantage for 
encapsulation approaches. Any application of ECM molecules or bioactive matrices for islet 
transplantation should take this into consideration. 
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Chapter 3 
CULTURING INS-1 CELLS ON CDPGYIGSR-, RGD- 
AND FIBRONECTIN SURFACES IMPROVES INSULIN 
SECRETION AND CELL PROLIFERATION 
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Titre en français : 
La culture des cellules INS-1 sur des surfaces modifiées avec CDPGYIGSR, RGD et 
fibronectine améliore la sécrétion d’insuline et la prolifération cellulaire 
 
Résumé : 
Des cellules d'insulinome de rat (INS-1), une lignée de cellules pancréatiques immortalisées 
sécrétant de l’insuline, furent cultivées sur des surfaces modifiées avec du carboxyméthyl-
dextrane (CMD). La fibronectine ainsi que le RGD et le CDPGYIGSR, une protéine et deux 
peptides de la matrice extracellulaire respectivement, furent greffés via un lien covalent sur les 
surfaces de CMD. Sur les surfaces de CMD, qui sont cytophobiques, et celles recouvertes de 
CMD+RGE, un control négatif pour le RGD, les cellules INS-1 étaient non-adhérentes et 
formaient des agrégats qui flottaient dans le milieu. Contrairement, sur les surfaces 
recouvertes de CMD+RGD, CMD+CDPGYIGSR et CMD+fibronectine, les cellules INS-1 
adhéraient tout comme sur les plaques à puits de polystyrène pour la culture tissulaire (TCPS), 
le control positif. Les cellules INS-1 sur les surfaces de CMD+fibronectine, CMD+RGD et 
CMD+CDPGYIGSR sécrétaient plus d'insuline à la suite d’une stimulation au glucose par 
rapport à celles sur le TCPS, CMD et CMD+RGE. Le taux de croissance cellulaire fut le plus 
élevé sur les surfaces de CMD+fibronectine et le plus bas sur les surfaces de CMD, et ce, 
après 7 jours de culture. Les cellules INS-1 liées aux surfaces de CMD+RGD et 
CMD+CDPGYIGSR avaient des taux de croissance nets inférieurs à ceux des cellules sur les 
surfaces de CMD+fibronectine mais plus élevés en comparaison avec ceux des cellules 
cultivées dans les autres conditions. L’expression d’E-cadhérine et des intégrines αvß3 et α5 
était similaire entre les différentes conditions, sauf pour l'expression de l’intégrine α5 sur les 
surfaces de CMD+fibronectine, CMD+RGD et CMD+CDPGYIGSR. Un plus grand nombre 
de cellules exprimait la protéine Ki-67 sur les surfaces CMD+CDPGYIGSR, TCPS, 
CMD+fibronectine et CMD+RGD. Dans toutes les conditions, les cellules exprimaient le 
Pdx1. 
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3.1 Abstract 
 
Rat insulinoma cells (INS-1), from an immortalised pancreatic beta cell line, were cultured on 
low-fouling carboxymethyl-dextran (CMD) layers bearing fibronectin, RGD or CDPGYIGSR, 
a laminin nonapeptide. INS-1 cells were non-adherent on CMD and RGE but adhered to 
fibronectin- and peptide-coated CMD surfaces and to tissue culture polystyrene (TCPS). On 
CMD bearing fibronectin and the peptides INS-1 cells showed higher glucose-stimulated 
insulin secretion compared to those on TCPS, bare CMD and RGE. INS-1 cells experienced a 
net cell growth, with the lowest found after 7 days on CMD and the highest on fibronectin. 
Similarly, cells on RGD and CDPGYIGSR showed lower net growth rates than those on 
fibronectin. Expression of E-cadherin and integrins αvβ3 and α5 were similar between the 
conditions, except for α5 expression on fibronectin, RGD and CDPGYIGSR. Larger numbers 
of Ki-67-positive cells were found on CDPGYIGSR, TCPS, fibronectin and RGD. Cells in all 
conditions expressed Pdx1. 
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3.2 Introduction 
 
One of the most promising treatments of insulin-dependent diabetes in humans is to graft 
isolated pancreatic islets to potentially restore the patient’s insulin production. The loss of 
extracellular matrix (ECM) during the isolation process is one of the many reasons for 
problems occurring after transplantation. Cell-ECM interactions are crucial for cell 
differentiation, migration, morphology, growth, function, and survival [200]. The islet ECM is 
constituted of an interstitial matrix and of a basement membrane. Laminin is the major 
component of the basement membrane and fibronectin is more abundantly found beneath 
endothelial cells and epithelial ducts in the interstitial matrix [201,202]. 
Fibronectin was shown to improve the proliferation of neonatal rat islet cells and, furthermore, 
prevent apoptosis [201,202]. Fibronectin is secreted endogenously as an inactive dimeric 
complex. When bound to its corresponding cell surface receptors (i.e., integrins), the complex 
is activated, which results in unfolding and subsequent fibril assembly of fibronectin. Thus, 
formation of the cell supporting network is initiated [203,204]. 
Laminins are heterotrimers formed by an alpha (α), a beta (β) and a gamma (γ) chain in 
multiple combinations [205]. It has been shown that laminins, either in purified form or as part 
of a cell-secreted matrix, improved pancreatic beta cell function and survival [206]. YIGSR, a 
synthetic laminin pentapeptide and the adhesion sequence of the β1 chain of laminin, 
encapsulated in a hydrogel, exhibited a pro-survival effect on beta cells [206]. The tripeptide 
Arg-Gly-Asp (RGD) is an integrin recognition sequence found in multiple ECM proteins like 
fibronectin, laminins, collagen type I, vitronectin, fibrinogen and others [207]. Approximately 
one third of the integrin receptor family recognises RGD. The tripeptide itself improves the 
resistance of isolated islets against apoptosis [55,208].  
Most recent efforts to immobilise ECM proteins or peptides have consisted of encapsulating 
these molecules in hydrogels using the cell-secreted 804G matrix, constituted of several ECM 
components [52]. Others have applied unspecific coating of surfaces using incubation of ECM 
molecules in solution [52]. 
In the present study, fibronectin, CDPGYIGSR, and RGD were covalently grafted on 
carboxymethyl-dextran (CMD)-covered tissue culture polystyrene (TCPS) plates. CMD itself 
has shown excellent non-adherence properties towards several cell types and was therefore 
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used as a negative control [209]. The cell type used for this study was INS-1, a rat insulinoma 
cell line secreting insulin following glucose stimulation. The culture of INS-1 cells on 
fibronectin-, CDPGYIGSR-, and RGD-covered CMD substrates was performed to compare 
the influence of the different molecules on insulin secretion, cell proliferation and cell-ECM 
interactions. 
 
3.3 Experimental Section 
3.3.1 Surface Preparation 
 
The preparation of the surfaces were performed by functionalising TCPS 12-well plates (3.84 
cm² surface area per well) with primary amines using plasma polymerisation of n-heptylamine 
(126802, Sigma-Aldrich, Oakville, ON, Canada) in a custom-built reactor as described 
elsewhere [210]. Briefly, n-heptylamine monomer pressure was stabilised at 0.040 Torr and 
glow discharged for 70 s at an ignition power of 80 W and at an excitation frequency of 50 
kHz. The distance between the electrodes was 10 cm. 
CMD was then immediately grafted on the amine-functionalised plates. Synthesis of dextran 
into 25% CMD and grafting on the plates have also been described in detail elsewhere [209]. 
Briefly, CMD was dissolved in Milli-Q water to yield a 2 mg·mL-1 solution which was then 
filtered through a 0.45 µm filter. By addition of 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC, E1769, Sigma-Aldrich) and N-hydroxysuccinimide 
(NHS, 130672, Sigma-Aldrich) to a concentration of 17 mM for 10 min, CMD was activated. 
The freshly n-heptylamine plasma polymer (HApp)-functionalised surfaces were covered with 
activated CMD solution and the reaction was allowed to proceed for 2 h at ambient 
temperature under agitation. The surfaces were then rinsed in 1 M NaCl solution (2 x 12 h) 
followed by rinsing in Milli-Q water (2 x 12 h) and stored at 4ºC until use. CMD surfaces have 
been shown to exert excellent low-fouling behaviour towards several cell types and proteins 
[211,212]. 
Peptide grafting was performed as described previously [209]. Briefly, GRGDS and GRGES 
(44-0-23 and 44-0-51, respectively, American Peptide, Sunnyvale, CA, USA) solutions were 
prepared to a final concentration of 50 µg·mL-1 in 1x (0.1 M) phosphate buffered saline (PBS, 
BP6651, Fisher Scientific, Ottawa, ON, Canada,). CMD surfaces were activated in a 200 mM 
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aqueous solution of EDC + NHS, rapidly rinsed in Milli-Q water and then covered in peptide 
solution. Samples were placed under agitation and the reaction was allowed to proceed for 2 h 
at ambient temperature followed by rinsing twice in 1x PBS. All peptide grafting was 
performed under sterile conditions. 
CDPGYIGSR (87-0-53, American Peptide Company) and fibronectin (Human Plasma 
Fibronectin, FC010, Millipore, Temecula, CA, USA) were covalently immobilised on CMD-
grafted 12-well TCPS plates using maleimide and carbodiimide chemistries, respectively. 
 
3.3.2 X-ray Photoelectron Spectroscopy (XPS) 
 
Surfaces were analysed using an AXIS ULTRA DLD spectrometer (Kratos Analytical Ltd., 
Manchester, UK) with a 225 W Al Kα source to validate the presence of the immobilised 
peptides. Elemental composition was determined with a survey spectrum at a pass energy of 
160 eV. CasaXPS (Casa Software Ltd.) was used to calculate the atomic concentrations of 
each element. Three separate areas of each surface were analysed. 
 
3.3.3 Cell Culture 
 
Rat insulinoma cells (INS-1, clone 832/13) [213,214] were cultured in RPMI-1640 with L-
glutamine (31800-022, Invitrogen) containing 10% foetal bovine serum (FBS, 12483, 
Invitrogen), 10 mM HEPES (H3375, Sigma-Aldrich), 1 mM sodium pyruvate (S8636, Sigma-
Aldrich) and 50 µM β-mercaptoethanol (M7522, Sigma-Aldrich). The culture medium was 
changed every 3 days. Upon confluence, cells were trypsinised and seeded onto the prepared 
surfaces at a density of 50,000 cells·mL-1. Cells were cultured for 7 days in all conditions. 
 
3.3.4 Glucose-Stimulated Insulin Secretion (GSIS) 
 
A GSIS test was performed with the 7-day cultures. For this purpose, the media were 
discarded and replaced with a low-glucose Krebs-Ringer buffer with HEPES (KRBH) solution 
supplemented with 2.8 mM D-Glucose. Samples were then incubated for 1 h. After, low-
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glucose KRBH was discarded and samples were rinsed with PBS. KRBH containing 28 mM 
D-Glucose was then added and samples incubated for 1 h. A rinsing step followed. Samples 
were then incubated for 1 h in KRBH supplemented with 28 mM D-Glucose + 50 µM 3-
isobutyl-1-methyl-xanthine (IBMX, I5879, Sigma-Aldrich) in KRBH. After a final rinsing 
step, samples were again incubated in low-glucose KRBH for 1 h. All media were collected 
and stored at -20°C for further insulin content measurement. Insulin content in the culture 
media was measured using an Insulin (Rat) High Range ELISA (enzyme-linked 
immunosorbent assay) kit (0.52 ng·mL-1 sensitivity; 80-INSRTH-E01, Alpco Diagnostics, 
Salem, NH, USA). Insulin content was normalised to the cell number for each condition. 
Absorbance was measured using a Synergy™ HT Multi-Detection Microplate Reader (Bio-
Tek, Winooski, VT, USA). 
 
3.3.5 Immunofluorescence 
 
Non-adherent INS-1 cultures (i.e., RGE and CMD) were collected into centrifuge tubes and 
centrifuged for 5 min at 1,200 rpm. Adherent cells (i.e., RGD, CDPGYIGSR, fibronectin, 
TCPS) were trypsinised (1 min, ambient temperature) and collected in stopping solution (10% 
FBS in PBS), then centrifuged for 5 min at 1,200 rpm. All cell pellets were rinsed with PBS, 
centrifuged and then fixed in 4% paraformaldehyde for 2 h at 4°C followed by 2% agarose and 
paraffin embedding according to standard protocols [200]. Paraffin sections were cut 
consecutively at a thickness of 4 µm. Primary antibodies to insulin (ab7842), E-cadherin 
(ab53033), αVβ3 (ab7166), Ki-67 (ab16667), pancreatic and duodenal homeobox 1 (Pdx1, 
ab47267) were purchased from Abcam (Cambridge, MA, USA). The primary antibody for the 
α5 integrin (sc-10729) was purchased from Santa Cruz (Santa Cruz, CA, USA). Secondary 
antibodies were obtained from Invitrogen. 
All sections were blocked in 10% goat serum and counterstained with 4’, 6-diamidino-2-
phenylindole, dihydrochloride (DAPI, D1306, Invitrogen). Manufacturer’s recommendations 
were used for pre-treatment, dilutions, incubation time and temperature. Samples were imaged 
using an epifluorescence microscope (Nikon Eclipse). 
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3.3.6 Ki-67 and Pdx1 Analysis 
 
Ki-67 and Pdx1 stained sections, processed as described in Section 3.3.5, were manually 
counted from fluorescent images taken at 60x magnification using the Simple PCI software 
(Hamamatsu Corporation). To estimate the percentage of Pdx1-positive cells, five independent 
fields for each condition were counted in triplicate. The average total cell number varied 
between 706 and 885 cells per repeat. Ki-67 sections were treated accordingly. Average cell 
numbers ranged between 327 and 838 cells per repeat. Data are presented as an average ± 
standard deviation (SD). 
 
3.3.7 Assay for Assessing Cell Number 
 
Cell numbers were quantified using a CyQUANT® assay (C35006, Invitrogen). Prior to 
carrying out this assay, non-adherent and adherent cells were collected as described in Section 
3.3.5 After centrifugation, the pellets were rinsed and re-suspended in Hanks buffered salt 
solution (HBSS) supplied with the assay and centrifuged a second time at 1,200 rpm for 1 min. 
Supernatant was removed and the cell pellet was re-suspended in dye solution for 1 h at 37°C 
in a 96-well TCPS plate. Fluorescence was measured using a Synergy™ HT Multi-Detection 
Microplate Reader (Bio-Tek). 
 
3.3.8 Statistical Analysis 
 
Data are presented as mean ± SD for 3 independent experiments. Differences in results were 
assessed by a single factor analysis of variance (ANOVA). A probability (P) value < 0.05 was 
considered statistically significant. 
 
3.4 Results and Discussion 
 
In this study, low-fouling surfaces with well-defined surface properties were used to graft 
ECM components in an attempt to compare their effect on proliferation and insulin secretion 
 40 
 
of INS-1 cells. The RGD and CDPGYIGSR peptides as well as fibronectin were covalently 
bound to low-fouling CMD surfaces, while TCPS served as positive control. Bare CMD and 
RGE surfaces were used as negative controls. This new approach allowed covalently linking 
of ECM-derived proteins and peptides, namely fibronectin, RGD and CDPGYIGSR, to CMD 
using maleimide and carbodiimide chemistry and, therefore, investigation of the specific 
ECM-cell interactions excluding the influence of FBS-derived proteins covering the surface. 
The XPS results (Table 3.1 and Fig. 3.1) confirmed that RGD, fibronectin, CDPGYIGSR, and 
RGE were covalently linked to the CMD surfaces. 
 
Table 3.1: XPS atomic concentration (%) and atomic ratio of HApp, HApp+CMD, 
HApp+CMD+CDPGYIGSR, HApp+CMD+Fibronectin, HApp+CMD+RGD and 
HApp+CMD+RGE. 
 
 
atomic concentration (%) atomic ratio 
O 1s C 1s N 1s O/C N/C 
HApp 1.8 90.8 7.4  0.02 0.08 
CMD 19.7 76.1 4.1  0.26 0.05 
CDPGYIGSR 20.03 74.18 5.61  0.27 0.08 
Fibronectin 19.0 73.2 8.1  0.26 0.11 
RGD 20.2 75.0 4.4  0.27 0.06 
RGE 19.6 76.0 4.4  0.26 0.06 
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Figure 3.1: High resolution XPS C 1s spectra of CDPGYIGSR, fibronectin, RGD and RGE 
surfaces and interlayers. 
 
Net cell growth had occurred for each culture condition, as shown in Figure 3.2 (CyQUANT 
assay), Figure 3.3 (percentage of Ki-67 positive cells) and supportive Figure A1 (Ki-67 
positive cells). Attached INS-1 cells showed higher net cell growth rates in general when 
compared to the postulated 100 h doubling time [10]. It was not surprising to obtain higher 
cell numbers on bioactivated surfaces in comparison with RGE and bare CMD surfaces. Cell 
net growth on fibronectin measured with the CyQUANT assay was significantly higher than 
on all other surfaces (p < 0.03), except RGD (p > 0.05). Due to cell-cell contacts within the 
INS-1 clusters formed in suspension on CMD or loosely bound on RGE, proliferation still 
occurred despite the low-fouling nature of the CMD and RGE surfaces [215]. 
  
 42 
 
 
Figure 3.2: INS-1 cell numbers after 7 days of culture on the different surfaces. Results 
represent the mean ± SD of 3 independent experiments (* p < 0.05). 
 
 
Figure 3.3: Percentage of INS-1 cells stained positively for Ki-67 after 7 days of culture on the 
different surfaces. Total cell numbers were obtained from DAPI staining. Results represent the 
mean ± SD of 3 independent experiments (* p < 0.05). 
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The highest percentages of cells positively stained for Ki-67 were found on CDPGYIGSR and 
TCPS (p < 0.004). One reason for this finding could be that cells on fibronectin and RGD 
were grown close to confluence, therefore, presumably being in a lag phase of growth. Despite 
that, more cells stained positively for Ki-67 on fibronectin and RGD than on CMD and RGE 
(p < 0.005 and p < 0.005, respectively). Additionally, Ki-67 is a proliferation marker found in 
all stages of the cell cycle except G0 [216]. Consequently, cells staining positively for Ki-67 
are not necessarily undergoing mitosis.  
When INS-1 cells were exposed to RGD, CDPGYIGSR, fibronectin and TCPS surfaces, they 
adhered to the surface tightly and began forming well-defined surface-bound clusters on RGD, 
CDPGYIGSR and fibronectin. Conversely, INS-1 cells were non-adherent when seeded on 
bare CMD and adhered only loosely on RGE, forming ‘islet-like’ aggregates in both 
conditions (Fig. 3.4). These findings indicate that INS-1 adherent cells use their ECM 
receptors to bind to the specific surface ligands. 
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Figure 3.4: Phase contrast microscopy pictures of INS-1 cells grown on the different surfaces 
after 72 h. 20x magnification. Bars correspond to 100 µm. 
 
Consequently, α5 and αVβ3 integrin expression was assessed. The α5-subunit binds exclusively 
to β1-integrin allowing an estimation of the α5β1-expression by staining for α5 only [25]. In 
previous studies, α5 expression has been observed during foetal rat pancreas development and 
β1 expression, when suppressed in adult rat pancreatic beta cells, was found to be pivotal for 
survival and migration of rat beta cells on a 804G matrix [52,55,217]. In contrast to those 
findings, α5 was expressed on all surfaces. This was surprising as cells on bare CMD and RGE 
surfaces have no access to ECM cues. Due to the low-fouling properties of both CMD and 
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RGE, cells cannot attach and, therefore, stay in suspension. Seemingly, in the non-adherent 
CMD and RGE systems, the α5 and αVβ3 integrins were dominantly expressed on cells residing 
in the core of the aggregates whereas expression on adherent surfaces was found ubiquitously 
as shown in Figure 3.5 (see also supportive Fig. A2, 100x magnification). One possible 
explanation for this strong expression could be the presence of ECM molecules synthesised by 
the INS-1 cells into the interstitial space of the aggregates. FBS-associated proteins are not be 
able to coat CMD-covered surfaces as these surfaces are low-fouling. The binding of INS-1 
cells to RGE, but not to CMD (Fig. 3.4), was most probably due to unspecific INS-1 surface 
receptor/RGE-interactions. If the TCPS plate on which the CMD was plated and RGE was 
immobilised was only slightly agitated, INS-1 cell-RGE aggregates detached immediately. 
Also, cell aggregates on RGE were morphologically closer to floating INS-1 aggregates on 
CMD than to the surface-bound cell clusters on RGD, fibronectin, CDPGYIGSR and TCPS. 
To ensure that differences between the CMD and RGE surfaces would be studied correctly, 
detachment of cell aggregates on RGE had been avoided. Therefore, unspecific cell 
attachment-related higher proliferation and α5 and αVβ3 integrin expression occurred on RGE.  
On CDPGYIGSR, RGD and fibronectin, expression of α5 seemed to be elevated as the 
intensity of the staining was more pronounced when compared to the other conditions. Both α5 
and αVβ3 integrins have been identified as RGD-binding integrins in pancreatic tissues 
[55,200]. Fibronectin contains multiple RGD motifs [202]. Therefore, INS-1 cells express 
both integrins to bind to RGD and fibronectin. In the case of CDPGYIGSR, the positive 
integrin staining was most probably due also to cell-derived ECM after 7-day culture. 
Additionally, the YIGSR motif interacts specifically with the 67kDa laminin receptor which 
has not been assessed in this study [218].  
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Figure 3.5: Expression of integrins α5 (red) and αVβ3 (green) of INS-1 cells cultured for 7 days 
on the different surfaces. Nuclei are stained with DAPI (blue). 60x magnification. Bars 
correspond to 50 µm. 
 
Cells on RGD and fibronectin as well as those on TCPS all expressed the αVβ3 integrin. It has 
previously been described that integrin αVβ3 plays a role in cell adhesion during pancreas 
development but this was recently shown to be less significant than with other αV integrins in 
foetal human islet preparations. Interestingly, the adult islet expression levels of αVβ3 were the 
same as those of foetal islets [219]. Our findings partially support those results as INS-1 cell 
expression of αVβ3 was overall weaker when compared to that of α5 integrin (Fig. 3.5). In 
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contrast, our results suggest that αVβ3 plays a role in INS-1 adhesion as it was expressed in all 
conditions.  
E-cadherin was shown to be essential for islet formation and recognition of the different cell 
types within the islet as it is expressed in β-cells only. The cadherin family consists of Ca2+-
dependent cell anchors which bind to cadherin homologues of neighbouring cells [220]. Here, 
β-cell E-cadherin expression was consistent with previous studies. E-cadherin was apparent 
and convincingly expressed throughout all conditions. Similar expression was detected on 
clustered cells grown on CDPGYIGSR, RGD and fibronectin but also in the CMD and RGE 
aggregates, which are both shown in Figure 3.6. CMD and RGE were selected to show the 
positive E-cadherin staining in general and to highlight the finding of E-cadherin expression in 
the non-adherent cultures. The cells on bare CMD surfaces, which stayed in suspension and 
the loosely bound cells on RGE most probably established cell-cell contacts to avoid 
detachment-induced apoptosis, known as anoikis [51].  
 
Figure 3.6: Immunofluorescence staining for E-cadherin of INS-1 cells cultured for 7 days on 
CMD and RGE. Nuclei are DAPI stained in blue. 60x magnification. Bars correspond to 50 
µm. 
 
As long term cultures of insulin-producing cells are of high interest for further studies and 
transplantation purposes, 7 day cultures were chosen. To examine the possibility of cell-
derived ECM deposition and alteration of the findings of this study, 3 day cultures were also 
stained for α5 and αVβ3 integrins and E-cadherin. No differences in expression levels between 
3 and 7 day cultures could be found as shown in supportive Figures A3 (α5 and αVβ3 integrin 
expression) and A4 (E-cadherin expression).  
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INS-1 cells were stained for insulin and glucagon to confirm purity of the cell line and to 
ensure the viability and function of the insulin-secreting cells. INS-1 cells expressed insulin 
but not glucagon after 7 days of culture throughout all conditions (supportive Figure A5). 
Previous studies using insulinoma cells found pseudo-islet formation in suspension. Insulin 
secretion of the pseudo-islets was negatively influenced by blocking E-cadherin [221]. In 
another study, pancreatic precursor cells, not detached from their ECM, formed so called 
‘islet-like’ cell aggregates [222]. Both these findings might help to explain the insulin 
expression and secretion seen on bare CMD and RGE surfaces supported by the E-cadherin-
mediated cell-cell adhesion.  
 
Figure 3.7: Glucose-stimulated insulin secretion (GSIS) of INS-1 cells cultured on different 
surfaces for 7 days. Insulin secretion was normalised per 106 cells. Results represent the mean 
± SD of 3 independent experiments (* p < 0.05). 
 
While all surface conditions resulted in glucose-stimulated insulin secretion (Fig. 3.7), INS-1 
cells on fibronectin and RGD secreted remarkably higher levels of insulin in comparison with 
the other culture conditions tested after stimulation with high glucose (p < 0.04) and 50 µM 
IBMX (p < 0.005). When stimulated with high glucose only, cells cultured on CDPGYIGSR 
did not secrete more insulin than cells cultured on TCPS. Inversely, when incubated with high 
glucose plus IBMX, cells grown on CDPGYIGSR secreted significantly more insulin than 
cells cultured on TCPS (p < 0.006). It has been shown that isolated human islets cultured in 
the presence of fibronectin, laminins, and collagens I and IV are able to maintain their abilities 
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to adhere, survive and function in an improved manner in vitro [223]. Hence, the higher 
insulin secretion on fibronectin and RGD is consistent with previous studies [51,200]. The 
higher secretion of insulin on the ECM surfaces is most probably due to the resulting ECM-
cell interactions [200]. 
Surprisingly, cells on RGE secreted approximately the same amount of insulin into the 
medium as cells on TCPS when normalised to cell number. INS-1 aggregates found on RGE 
did not secrete significantly more insulin than those on CMD. INS-1 cells cultured on CMD 
and RGE both formed ‘islet-like’ clusters (Fig. 3.4). Therefore, it is possible to compare them 
to MIN-6 pseudo-islets in both function and proliferation behaviour as they maintain their 
ability to secrete insulin in response to glucose [221]. 
Recent studies showed that cancerous or transformed beta cell lines with high proliferation 
e.g., INS-1 or MIN-6 cells, produce and secrete less insulin than primary beta cells [224]. 
Therefore, the relatively low insulin secretion of cells grown on CDPGYIGSR when 
stimulated with 28 mM glucose could be explained by the observed high proliferation rates on 
CDPGYIGSR, as revealed from cells staining positively for Ki-67. In contrast to these 
findings, INS-cells on CMD and RGE with the lowest levels of positive Ki-67 staining 
secreted relatively less insulin than INS-cells in all other conditions. Possibly, cell aggregates 
on CMD and RGE were negatively influenced by the lack of ECM-cell support showing less 
integrin expression compared to the other conditions. 
Additionally cells in all conditions expressed Pdx1 (supportive Figure A6). The relative 
numbers of cells grown on fibronectin, RGD, CDPGYIGSR and TCPS and expressing Pdx1 
were larger than those on CMD and RGE (p < 0.002 and p < 0.02, respectively) (Figure 3.8). 
The transcription factor Pdx1 is essential for pancreas development and maintenance of beta 
cell function and survival [225]. The interaction between insulin and Pdx1 seems to prevent 
islets from undergoing apoptosis [226]. Our results suggest that ECM-cell interactions 
promoted by the surface-immobilised fibronectin, RGD and CDPGYIGSR enhance insulin 
secretion and the number of cells expressing Pdx1 via integrin-receptor activation. This is 
supported by a study conducted by Krishnamurthy et al. [214] showing that perturbation of 
integrin function results in decreased human islet and INS-1 cell proliferation, Pdx1 
expression and decreased insulin expression and secretion. 
  
 50 
 
 
Figure 3.8: Percentage of INS-1 cells stained positively for Pdx1 after 7 days of culture on the 
different surfaces. Total cell numbers were obtained from DAPI staining. Results represent the 
mean ± SD of 3 independent experiments (* p < 0.05). 
 
3.5 Conclusions 
 
Globally, we have demonstrated that INS-1 cells cultured on substrates bearing low-fouling 
carboxymethyl-dextran (CMD) layers, on which fibronectin, RGD and CDPGYIGSR were 
covalently linked, exhibited higher insulin secretion and cell proliferation compared to the 
controls CMD, RGE and TCPS. These well-defined surfaces could be used for further 
characterisation of ECM-beta cell interactions, thus, leading to a better understanding of beta 
cell function and, subsequently, of diabetes and pancreas development. Additionally, the 
surfaces could be tested with isolated human islets to investigate their effect over islet survival 
and insulin secretion in response to glucose. 
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Chapter 4 
YOUNG PORCINE ENDOCRINE PANCREATIC 
ISLETS CULTURED IN FIBRIN SHOW IMPROVED 
RESISTANCE TOWARDS HYDROGEN PEROXIDE  
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Titre en français : 
L’enrobage dans la fibrine d’îlots pancréatiques endocriniens isolés de jeunes porcs et exposés 
au peroxyde d’hydrogène améliore la survie et les fonctions des îlots. 
 
Résumé : 
Objectif : Étudier l'effet protecteur d'un gel de fibrine sur la survie et les fonctions d’îlots 
pancréatiques endocriniens isolés de jeunes porcs et exposés au peroxyde d'hydrogène dans le 
contexte de la transplantation d’îlots. 
Méthodes : Après l'isolation et la maturation in vitro, des groupes de 200 équivalents d'îlots 
(IEQ) isolés de jeunes porcs étaient incorporés dans un gel de fibrine (200 µL). Ceux-ci étaient 
exposés à deux concentrations (10 µM et 100 µM) de peroxyde d'hydrogène (H2O2) pour 
étudier la capacité de la fibrine à protéger les îlots contre des stimuli apoptotiques. À titre de 
contrôle, des îlots porcins étaient cultivés dans des plaques à multi-puits de polystyrène 
vendus pour la culture tissulaire (TCPS) et exposés aux mêmes concentrations de H2O2. 
L'intégrité des îlots, leur viabilité et leurs fonctions étaient ensuite étudiées. 
Résultats : L'intégrité des îlots incorporés dans des gels de fibrine était mieux préservée par 
rapport à celle des îlots cultivés dans le TCPS. Les marquages par immunofluorescence ont 
montré que l’expression d'insuline et de glucagon était plus élevée dans les îlots cultivés dans 
la fibrine. En général, l’incubation avec le H2O2 causait une diminution de l’expression de 
l’insuline et du glucagon. Une mesure d’apoptose avec un test TUNEL révélait des nombres 
élevés de cellules apoptotiques pour les îlots cultivés dans des plaques de TCPS par rapport à 
ceux intégrés dans la fibrine. La capacité de sécréter de l’insuline en réponse au glucose était 
diminuée dans les îlots cultivés dans les plaques de TCPS après l’exposition au H2O2. Les îlots 
incorporés dans la fibrine maintenaient leur réactivité au glucose. L'insuline piégée dans la 
fibrine a été extraite et quantifiée, révélant de faibles concentrations d’insuline dans l'extrait. 
Conclusions/Interprétation : La fibrine a un effet protecteur sur les îlots pancréatiques 
endocriniens isolés de jeunes porcs et exposés au peroxyde d'hydrogène. 
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4.1 Abstract 
 
Aim: To study the protective effect of a fibrin scaffold towards embedded young porcine 
endocrine pancreatic islets from hydrogen peroxide within the context of islet encapsulation in 
transplantation. Methods: After isolation and in vitro maturation, groups of 200 young porcine 
islet equivalents (IEQ) were embedded in a 200 µL fibrin gel and exposed to two 
concentrations (10 µM and 100 µM) of hydrogen peroxide (H2O2) to investigate the ability of 
fibrin to protect islets against apoptotic stimuli. As a control, young porcine islets were seeded 
in tissue culture polystyrene (TCPS) well plates and exposed to the same H2O2 concentrations. 
Islet integrity, viability and function were then investigated. Results: Morphologically, the 
integrity of islets embedded in fibrin gels was better preserved compared to that of islets 
cultured in TCPS plates, when exposed to H2O2. Immunofluorescence staining showed that 
insulin and glucagon expression was higher in islets cultured in fibrin. Overall, H2O2 
incubation led to decreased insulin and glucagon expression. A TUNEL assay revealed 
elevated numbers of apoptotic cells for islets cultured in TCPS plates when compared to those 
embedded in fibrin. Islets cultured in TCPS plates and exposed to H2O2 had diminished ability 
to secrete insulin in response to glucose stimulation, whereas islets embedded in fibrin 
maintained their glucose responsiveness. Insulin trapped in fibrin was extracted and 
quantified, revealing low levels of insulin in the extract. Conclusions/Interpretation: Fibrin has 
a protective effect on young porcine endocrine pancreatic islets exposed to hydrogen peroxide. 
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4.2 Introduction 
 
This study follows the hypothesis that cell-extracellular matrix interactions improve islet 
integrity, viability and function after exposure to immune system-derived apoptotic stimuli, 
such as hydrogen peroxide (H2O2). Apoptotic stimuli such as H2O2 are present during type 1 
diabetes mellitus (T1DM) onset, autoimmune beta cell destruction, and after islet 
transplantation. Islet transplantation could offer a cure for T1DM as the islet graft could 
restore adequate endogenous insulin secretion for the patient. Even after the introduction of 
the Edmonton’s protocol, islet transplantation is still attempting to overcome the low success 
rates associated with cellular or functional loss of the graft [112]. Two reasons for loss of such 
a graft include damage to the native extracellular matrix (ECM) after isolation and 
transplantation, and later, rejection of the donor graft by the host’s immune system [111]. One 
of the macrophage-secreted mediators of the immune system response is H2O2, a microbicidal, 
cytotoxic, and tissue damaging, small and uncharged molecule which can easily pass through 
the cell membrane [227]. Physiological H2O2 concentrations during inflammation can range 
between 5 and 15 µM [228]. Recent studies have shown that the islet ECM, and more 
specifically, cell-integrin interactions, mediate apoptosis resistance and support viability and 
function of pancreatic beta cells [52,200]. Fibrin, a transient in vivo ECM, has been used to 
improve culture conditions for mouse and human pancreatic islets before transplantation 
[40,45]. Mouse islets pre-cultured in fibrin and implanted in mice have shown improved 
survival, increased insulin content and yielded a larger population of functional islets [40]. 
Human islets embedded in fibrin gels enriched with perfluorodecalin showed less apoptosis 
and, compared to the controls, maintained their insulin secretion in response to glucose [45]. 
It is hypothesized that fibrin protects young porcine endocrine pancreatic islets from hydrogen 
peroxide. In accordance, culturing young porcine endocrine pancreatic islets embedded in 
fibrin could improve pre- and post-transplantation-related complications, thus improving islet 
integrity, viability and insulin secretion. This study is a first step towards improved xeno-islet 
grafts for human transplantation. 
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4.3 Results 
4.3.1 Islets in Fibrin Maintained Their Typical Morphology Whereas Islets 
Cultured in TCPS Plates Dispersed 
 
Figure 4.1: Morphology of young porcine endocrine pancreatic islets cultured for 12 h in 
TCPS plates with no H2O2 (A), 10 µM H2O2 (B) and 100 µM H2O2 (C). Morphology of islets 
cultured for 12 h in fibrin with no H2O2 (D), 10 µM H2O2 (E) and 100 µM H2O2 (F). 10x 
magnification. Bars represent 50 µm. 
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After the overnight culture and 12 h incubation with 0, 10 and 100 µM H2O2, islets cultured in 
fibrin showed the first signs of sprouting, forming capillary-like structures (Fig. 4.1 D-E). The 
occurrence of sprouts decreased with increasing H2O2 concentrations. Islets in fibrin were 
viable with little or no effect from H2O2. Almost no single cells could be observed in 
proximity of the islets, indicating that islets in fibrin did not start to disintegrate. Islets cultured 
in TCPS plates were dispersed after incubation with 100 µM H2O2. The grade of dispersion 
increased with the H2O2 concentration (Fig. 4.1 A-C). 
 
4.3.2 Islets Cultured in Fibrin Maintained Their Responsiveness to Glucose 
Concentrations and Secreted More Insulin than Islets in TCPS Plates 
 
The results of the glucose-stimulated insulin secretion (GSIS) assay performed after the 12 h 
H2O2 incubation indicated that islets in fibrin not only maintained their responsiveness to 
different glucose concentrations but also secreted relatively more insulin when compared to 
their respective controls in TCPS (Fig. 4.2 A). As shown in Figure 4.2, the insulin secretion of 
islets in TCPS exposed to 10 and 100 µM H2O2 were normalized to the insulin secretion of 
islets in TCPS cultured without H2O2 in response to the initial low glucose concentration (LG) 
conditions. Similarly, the insulin secretion of islets embedded in fibrin exposed to 10 and 100 
µM H2O2 were normalized to the insulin secretion of islets in fibrin cultured without H2O2 in 
response to the initial low glucose concentration (LG) conditions. In addition, absolute insulin 
secretion of 3 islet batches in 3 repeats is shown in Figure 4.2 B to demonstrate why relative 
insulin secretion was chosen over absolute insulin secretion in this study.  
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A 
 
B 
 
Figure 4.2: (A) Relative insulin secretion of young porcine endocrine pancreatic islets after 1h 
stimulation with low glucose concentration (LG, 2.8 mM), high glucose concentration (HG, 28 
mM), high glucose concentration + 3-isobutyl-1-methylxanthine (IBMX) (HI, 28 mM + 
IBMX) and a second low glucose concentration (LG2, 2.8 mM) concentration. Insulin 
secretion of islets in TCPS/fibrin was normalized to the insulin secretion of islets in 
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TCPS/fibrin with no H2O2 in response to low glucose concentration. (B) Three repeats of a 
glucose-stimulated insulin secretion assay with LG, HG, HI and a final LG. Shown are the 
insulin contents in the media (µg per L) of porcine pancreatic islets (200 IEQ) cultured on 
TCPS (T) or in fibrin gels (F) with 0, 10 or 100 µM H2O2.’*’ represents a value of p < 0.05, 
‘ns‘ means no statistical significance. 
 
Analysis of the extract revealed that some insulin remained trapped within the fibrin gels (Fig. 
4.3). The mass of insulin secreted by 200 IEQ in fibrin with no exposition to H2O2 and by 
those in fibrin exposed to 100 µM H2O2 was 0.26 and 0.20 µg, respectively. Therefore, 
approximately 5-6 % of the total mass of insulin remained trapped in the fibrin mesh. Further 
development is needed to develop an extraction protocol to quantify the insulin trapped in the 
fibrin. 
 
Figure 4.3: Mass of insulin (in µg) secreted into the media by 200 IEQ embedded in fibrin and 
exposed to 0 (F0) and 100 µM H2O2 (F100) and the mass of insulin (in µg) in the extract of 
fibrin gels rinsed with 500 µL PBS and centrifuged thereafter. 
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4.3.3 Insulin and Glucagon Expression is Diminished in Islets Cultured in 
TCPS Plates 
 
Immunofluorescence staining for insulin and glucagon was performed (Fig. 4.4). Cells 
staining positively for insulin were manually counted. At least 10 random fields per condition 
were examined, containing an average of 3 islets per field. Islets cultured in fibrin and on 
TCPS plates showed decreasing insulin and glucagon expression with increasing H2O2 
concentration and when compared to the ‘Time Zero’ control (Table 4.1). On TCPS, islets had 
a lesser number of insulin-positive cells than glucagon-positive cells and overall lower levels 
of expression of both molecules as opposed to fibrin. Islet cells cultured in fibrin had higher 
numbers of insulin-positive cells than glucagon-positive cells but overall lower expression of 
both molecules when compared with islets at ‘Time Zero’.  
 
Figure 4.4: Immunofluorescence staining for insulin (green) and glucagon (red) of young 
porcine endocrine pancreatic islets. Nuclei are DAPI stained in blue. 40x magnification. Bars 
represent 100 µm. 
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Table 4.1: Number of cells stained positively for glucagon, insulin, and both glucagon and 
insulin, counted on immunofluorescence images of porcine pancreatic islets at ‘Time Zero’, in 
fibrin with no (F0), 10 (F10), and 100 (F100) µM H2O2, and on TCPS with no (T0), 10 (T10), 
and 100 (T100) µM H2O2. Percentages of glucagon- and insulin-positive cells are shown in 
brackets. 
Condition Total number of 
cells counted* 
(100 %) 
Glucagon positive 
cells 
Insulin positive 
cells 
Positive cells 
Time Zero 1925 443 (23.0 %) 548 (28.5 %) 991 (51.5 %) 
F0 2332  403 (17.3 %)  482 (20.7 %) 885 (38.0 %) 
F10 2348 319 (13.6 %) 433 (18.4 %) 752 (32.1 %) 
F100 2746 164 (6.0 %) 301 (11.0 %) 365 (16.9 %) 
T0 4174 735 (17.6 %)   368 (8.8 %) 1103 (26.4 %) 
T10 3725 314 (8.4 %) 194 (5.2 %) 508 (13.6 %) 
T100 2908 144 (5.0 %) 104 (3.6 %) 248 (8.5 %) 
* Variations in the cell numbers counted depend on sample sizes, which vary from one 4µm-
thick paraffin section to another. 
 
4.3.4 Integrin α5 is Strongly Expressed in Fibrin-Embedded Islets 
 
Islets were stained for the αVβ3 and α5 integrins. The staining for αVβ3 was overall very weak 
(data not shown) and showed no differences between the culture conditions. In contrast, the 
integrin α5 was expressed more strongly in islets cultured in fibrin compared with islets on 
TCPS (Fig. 4.5). A decrease in integrin α5 could be noted with increasing H2O2 concentration. 
Table 4.2 shows a manual counting of at least 5 fields with an average of 3 islets per field. A 
higher percentage of cells stained positively for α5 integrin in the fibrin set when compared to 
islets on TCPS. 
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Figure 4.5: Immunofluorescence staining for integrin α5 (red) of young porcine endocrine 
pancreatic islets. Nuclei are DAPI stained in blue. 20x magnification. Bars represent 50 µm. 
 
Table 4.2: Number of cells stained positively for integrin α5, counted on immunofluorescence 
images of porcine pancreatic islets at ‘Time Zero’, in fibrin with no (F0), 10 (F10), and 100 
(F100) µM H2O2, and on TCPS with no (T0), 10 (T10), and 100 (T100) µM H2O2.  
Condition Total number of cells 
counted* 
(100 %) 
Integrin α5 positive 
cells 
Percentage 
(positive) 
Time Zero 2644 779 29.5 % 
F0 2541 1790 70.4 % 
F10 2253 1206 53.5 % 
F100 2300 1116 48.5 % 
T0 2798 836 29.9 % 
T10 2236 398 17.8 % 
T100 2591 332 12.8 % 
* Variations in the cell numbers counted depend on sample sizes, which vary from one 4µm-
thick paraffin section to another. 
 
4.3.5 Fibrin Embedding Protects Islets Against Apoptosis 
 
Paraffin sections of islets in each condition were treated with a TUNEL assay and then imaged 
and counted. At least 10 random fields of each condition performed in triplicate were counted 
manually (Fig. 4.6 A, 4.6 B). All brownish and black spots within the cell nuclei were 
counted. Fibrin-embedded islet cells were significantly less apoptotic than the islet cells in 
 64 
 
TCPS plates. The incidence of apoptosis increased with increasing H2O2 concentrations (Fig. 
4.6 C). 
 
A           B 
 
C 
 
Figure 4.6: Light microscopy images of young porcine endocrine pancreatic islets treated with 
the APO-BrdU IHC staining kit. 40x magnification. Islets cultured in TCPS plates with 0, 10 
or 100 µM H2O2 compared to time zero (A) and islets embedded in fibrin with 0, 10 or 100 
µM H2O2 compared to time zero (B) are shown. The percentage of apoptotic cells (brown) in 
the total cell population (blue and brown) is shown in Fig. 4.6C. ’*’ represents a value of p < 
0.05, ‘***’ represents a value of p < 0.001. *** compared Time Zero with T10 and Time Zero 
with T100 and each T-set compared to the corresponding F-set. 
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4.4 Discussion 
 
This study confirms fibrin has a protective effect when used to embed young porcine 
endocrine pancreatic islets after exposure to H2O2 (10 and 100 µM). It is known that 
pancreatic islets are separated from their ECM after isolation and consequently lose their 
typical spherical morphology and disperse if cultured in suspension [40]. Islet cells may suffer 
from anoikis, a form of apoptosis induced by cell detachment from its ECM [51]. 
Additionally, in this study, elevated islet dispersion in suspension was observed with 
increasing concentrations of H2O2 whereas islets cultured in fibrin exhibited sprouting 
formation. It has been shown that fibrin gels promote microvessel formation and re-
vascularisation of pancreatic porcine islet grafts in mice when transplanted subcutaneously 
[41]. 
Recent studies showed that interactions between pancreatic islets and their ECM regulate 
insulin secretion and cell proliferation, and prevent apoptosis [208,229]. In this study we 
showed that islets cultured on TCPS lost their glucose responsiveness when exposed to H2O2, 
whereas islets embedded in fibrin maintained it and even secreted relatively more insulin in 
response to glucose (Fig. 4.2). Without the provision of a three-dimensional environment, 
isolated pancreatic islets undergo more apoptosis than islets supported by fibrin, agarose, 
collagen and/or other ECM-like networks during a given culture period before being 
transplanted. When recovered from those matrices and transplanted, islets showed improved 
resistance towards apoptosis and improved survival when exposed to the immune system of 
the host. A higher insulin secretion in response to glucose was also observed in those islets 
[40,45,59,200,208,229]. In our cultures, relative insulin secretion was also higher in the fibrin 
set with islets maintaining their glucose responsiveness whereas non-embedded TCPS cultures 
did secrete insulin but were not able to respond to higher glucose concentrations (Fig. 4.2 A). 
Our results confirm that fibrin-embedded islets are significantly less apoptotic even after 
exposure to 10 or 100 µM H2O2 compared to islets cultured in TCPS plates. The two different 
H2O2 concentrations were chosen to represent a physiological concentration i.e., 10 µM, and a 
higher concentration i.e., 100 µM, shown to induce elevated levels of apoptosis [228,230]. 
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Insulin and glucagon expression was better preserved in islets cultured in fibrin (Table 4.1) but 
diminished with increasing H2O2 concentrations. Overall, numbers of glucagon- and insulin-
positive cells appeared to be low, with just 52.5 % of all cells at ‘Time Zero’ staining 
positively for both. After islet culture, decreasing percentages were observed. These relatively 
low numbers could be due to the time passed between isolation and culture, the culture time 
itself, the varying cell composition of pancreatic islets, and/or even the region of origin of the 
islets within the pancreas [231]. 
One possible explanation for the beneficial effects of fibrin on the survival of pancreatic islets 
after H2O2 exposure could be cell-integrin-fibrin interactions [208]. It has been shown, that 
integrins are essential for islet survival, resistance to apoptosis, and islet cell maintenance 
[52,60,200]. Porcine pancreatic islets express several integrins e.g., αV and α5 [54]. We found 
evidence that islets in fibrin and on TCPS expressed integrins, αVβ3 and α5, with a much 
weaker overall αVβ3 expression. Integrin α5 was expressed more strongly in islets cultured in 
fibrin than in islets on TCPS and expression decreased with increasing H2O2, indicating a 
possible integrin-dependent protective effect of fibrin towards pancreatic islet cultures (Table 
4.2). After a 12 h culture in fibrin, integrin α5 was stronger in fibrin cultures than in islets 
fixed, processed and stained right after arrival at ‘time zero’, suggesting that fibrin triggers 
integrin expression in islets. This is supported by recent findings, that the postulated protective 
effect of fibrin could be related to availability of binding sites in the fibrin mesh for the islet 
cell integrins [51,52,208]. Further investigation on integrin expression of islets in fibrin gels 
should be undergone as immunofluorescence staining is mostly a qualitative method and 
differences in expression are based on manual counting from images. On the other hand, more 
quantitative methods such as RT-PCR and Western blotting pose several problems when 
working with tissues or cells embedded in gels, as the extraction of the cell materials from the 
tissues (here, the islets) embedded in fibrin, without affecting the cells, is challenging. Finally, 
it can be argued that fibrin could simply constitute a mechanical barrier protecting the islets by 
delaying H2O2 diffusion. It has previously been shown that rhodamine B, a fluorescent dye 
with a molar mass of 479.02 g·mol-1, diffuses quite rapidly in fibrin gels (2 mg fibrinogen per 
mL) [232] considering the time scale (12 h) of the H2O2 experiments. Therefore, it can be 
assumed that the diffusion of H2O2, with a molar mass of 34 g·mol-1, was not hindered through 
the fibrin matrix. Interestingly, fibrin was found to retain small amounts of insulin. 
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Theoretically, more insulin could be trapped inside the gels because the extraction method 
used to extract insulin does not guarantee that all of the insulin was recovered. Possible 
implications could be falsely low or high insulin production in 3D cultures, misinterpretation 
of data and even the impossibility of extracting trapped insulin from the gel and, therefore, 
losing important information. Currently, valid extraction methods are being investigated in our 
group.  
This study revealed that fibrin, when used to embed young porcine endocrine pancreatic islets, 
protects those islets from the destructive effects of H2O2. In the context of islet transplantation, 
these results suggest that fibrin could provide protection for such a graft. Further studies with 
endocrine pancreatic islets embedded in fibrin will include immune cells and immune system-
derived effectors to further investigate the potential protective effects of fibrin. 
 
4.5 Materials and Methods 
4.5.1 Isolation of Young Porcine Endocrine Pancreatic Islets 
 
Young porcine endocrine pancreatic islets were provided by the islet isolation facility at the 
Department of Surgery, University California Irvine, under the ethical protocol IACUC 
#2008-2823. Pancreata from young Yorkshire pigs (14 - 22 days) were removed using rapid 
surgical procurement and placed in University of Wisconsin (UW) solution for organ 
preservation. 
Pancreata were minced and digested in a low dose collagenase MA/BP protease enzyme 
mixture (001-2020, Vitacyte) for 15 ± 2 min in a 37°C water bath and mixing at 60 rpm. Cold 
(4°C) HBSS supplemented with HEPES and 10% BSA was added to the tissue-enzyme 
mixture to stop enzymatic digestion and the partially digested tissue was force-filtered through 
a 500 µm metal mesh. 
Tissue clusters were then cultured at 37°C, 5% CO2 in T-175 suspension flasks in media. The 
medium used was a novel culture medium supplemented with proteins and enzymes designed 
to improve beta cell function (GLP-1 antagonists, insulin, etc.) and exclusion of exocrine 
tissue, and containing 10 % porcine serum [233]. The islets were allowed to mature for 8 days 
with media changed every 48 hours, which has been shown to further decrease exocrine tissue 
[234]. After which, samples for islet counts as well as for islet viability and function were 
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taken and aliquots were collected, packaged in a 50 mL conical tube with culture medium and 
shipped via overnight express shipment at room temperature. The total number of IEQ has 
been calculated as described elsewhere [234].  
 
4.5.2 Young Endocrine Porcine Islet Culture 
 
Upon arrival, porcine endocrine pancreatic islets were inspected, washed and placed in fresh 
media made of CMRL-1066 medium (11530, Invitrogen) containing 10 % foetal bovine serum 
(FBS, 12483, Invitrogen), 25 mM HEPES (H3375, Sigma-Aldrich), 1 % penicillin-
streptomycin (15140-122, Invitrogen) and 2 mM L-glutamine (25030-149, Invitrogen) at pH 
7.4. Islets were either embedded and cultured in fibrin gels or cultured in tissue culture 
polystyrene (TCPS) plates. Fibrin gels with a total volume of 200 µL (2 mg·mL-1 bovine 
fibrinogen, F8630, Sigma-Aldrich) containing 200 IEQ were prepared in a 48-well TCPS plate 
as described previously [235]. After jellification with 1U·mL-1 bovine thrombin (T9549, 
Sigma-Aldrich), the gels were covered with 200 µL of medium. An equal number of islets was 
re-suspended in 200 µL of medium and seeded in a 48-well TCPS plate. 
 
4.5.3 Islet Incubation with Hydrogen Peroxide (H2O2) 
 
After overnight culture, media were removed and replaced with 200 µL of either fresh 
medium with no H2O2, 200 µL of fresh medium containing 10 µM H2O2 (H3410, Sigma-
Aldrich), or 200 µL of fresh medium containing 100 µM H2O2. The islets were then incubated 
for 12 h. 
 
4.5.4 Glucose-stimulated Insulin Secretion (GSIS) and Insulin Entrapment 
in Fibrin Gels 
 
A GSIS test was performed after the 12 h H2O2 incubation as described in detail elsewhere 
[236]. 2.8 mM glucose solutions served as low glucose (LG) step, 28 mM glucose solutions 
were used representing high glucose (HG) concentrations. An additional incubation step with 
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28 mM glucose + 50 µM 3-isobutyl-1-methyl-xanthine (IBMX; I5879, Sigma–Aldrich) was 
performed. Different glucose solutions were incubated for 1 h each in the sequence LG, HG, 
HI, and LG2. Insulin contents were measured using either an Insulin Porcine High Range 
ELISA kit (0.313 µg·L-1 sensitivity; 10-1223-01, Mercodia Inc.) or an Insulin Porcine ELISA 
kit (0.01 µg·L-1 sensitivity; 10-1200-01, Mercodia Inc.). Insulin content of the media was 
normalized to the volume of medium for each condition. 
An attempt was made to extract insulin from fibrin gels containing the islets, by rinsing the 
gels with 500 µL PBS and centrifuging them for 20 s (12,800 rpm). The insulin content of the 
fibrin extract was expressed as µg per 200 IEQ. Absorbance was measured using a Safire2 
microplate reader (Tecan Group Ltd.). 
 
4.5.5 Immunofluorescence 
 
Islets in TCPS plates and in fibrin gels were collected into centrifuge tubes, fixed in 4 % 
paraformaldehyde and processed for paraffin embedding. Immunofluorescence staining was 
performed according to standard protocols with paraffin sections consecutively cut at a 
thickness of 4 µm. Primary antibodies to insulin (ab7842), glucagon (ab18461) and αVβ3 
integrin (ab7166) were purchased from Abcam. The primary antibody for the α5 integrin (sc-
10729) was purchased from Santa Cruz. As secondary antibodies, a goat anti-mouse IgG 
Alexa Fluor® 488 (A11001, Invitrogen) and a goat anti-rabbit IgG Alexa Fluor® 555 
(A21428, Invitrogen) were used. All sections were blocked in 10% goat serum and 
counterstained with DAPI (D1306, Invitrogen). Manufacturer’s recommendations were used 
for pre-treatment, dilutions, incubation time and temperature. Samples were imaged using an 
epifluorescence microscope (Nikon Eclipse). 
Insulin and integrin α5 positive cells were counted manually. For each condition, at least 5 
fields with an average of 3 islets on each were counted. The total cell population was 
represented by DAPI positive cells. The percentage of cells staining positively for insulin or 
integrin α5 over the total cell population was assessed.  
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4.5.6 TUNEL Apoptosis Assay 
 
Paraffin sections of pancreatic islets cultured in fibrin or in TCPS plates were treated with an 
APO-BRDU-IHCTM* kit (AH1001, Phoenix Flow Systems) to measure apoptosis by dual color 
immunohistochemistry. Since apoptosis is leading to a multitude of 3’-hydroxyl ends in the 
fragmented DNA, those ends can be labeled with Br-dUTP. A combination of biotin-labeled 
anti-BrdU antibody, horseradish peroxidase streptavidin conjugate, DAB and H2O2/Urea 
results in a brownish-black color generation in apoptotic nuclei whereas a methyl green 
solution for counter staining results in a light blue color of all cells within the population. 
After deparaffinization, samples were rehydrated and permeabilized with Proteinase K (1:100 
in 10 mM Tris pH 8) at room temperature (RT) for 20 min. Following a PBS rinsing step, 
endogenous peroxidases were inactivated using 3 % H2O2 in methanol (at RT for 5 min). After 
rinsing in PBS, samples were equilibrated with a reaction buffer provided with the kit, diluted 
in distilled water, at RT for 30 min. Immediately after equilibration, the DNA labeling 
solution containing the reaction buffer, TdT enzyme, Br-dUTP and distilled water was applied 
for 90 min at 37 °C with samples placed in a humid chamber. All samples were then rinsed 
with PBS. This was followed by 10-min incubation with a blocking buffer at RT. After, 
antibody solution containing anti-BrdU-biotin and blocking buffer was applied to each sample 
for 90 min at RT in a humid chamber. Samples were covered with blocking buffer after 
rinsing with PBS. A conjugate solution made in blocking buffer was then applied for 30 min at 
RT, followed by a PBS rinse. DAB solution (DAB/H2O2/Urea in tap water) was added and 
incubated for 5 min at RT. Samples were rinsed with tap water and, immediately after, 
covered with a methyl green counterstain solution at RT for 5 min. Slides were dipped in 100 
% ethanol and, later xylene, before being mounted with a Permount solution (SP15100, Fisher 
Scientific). Samples were imaged with a Leica DMR HCS microscope system. 
 
4.5.7 Statistical Analysis 
 
Data are presented as means ± SD for 3 independent experiments. Differences in results were 
assessed by a single factor ANOVA. A probability (P) value < 0.05 was considered 
statistically significant,  p < 0.001 was considered highly statistically significant. 
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Chapter 5 
YOUNG PORCINE ENDOCRINE PANCREATIC 
ISLETS CULTURED IN FIBRIN AND ALGINATE 
GELS SHOW IMPROVED RESISTANCE TOWARDS 
HUMAN MONOCYTES 
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Titre en français : 
L’enrobage dans la fibrine et l’alginate d’îlots pancréatiques endocriniens isolés de jeunes 
porcs offre une protection pour les îlots lorsqu’exposés à des monocytes humains. 
 
Résumé : 
But : Étudier la protection offerte par les gels de fibrine et d’alginate utilisés pour enrober des 
îlots pancréatiques endocriniens isolés de jeunes porcs et exposés à des monocytes humains. 
Méthodes : Des groupes de 200 équivalents d'îlots (IEQ) isolés de jeunes porcs étaient 
incorporés dans un gel de fibrine ou d’alginate (200 µL) ou dans le contrôle negatif, les 
plaques à multi-puits de polystyrène vendus pour la culture tissulaire (TCPS). Ceux-ci étaient 
exposés aux 2x105 monocytes humaines pour 24 h. En plus, les monocytes et les îlots étaient 
cultivés séparément. La morphologie, la viabilité et la fonction des îlots enrobés et cultivés en 
suspension dans les milieux de culture étaient évaluées, ainsi que la sécrétion de cytokines par 
les monocytes. 
Résultats : Lorsque flottant dans les plaques de TCPS, les îlots non-encapsulés étaient 
encerclés par les monocytes et commençaient à se désintégrer après 24 h. Dans la fibrine, des 
monocytes étaient observés à proximité des îlots, indiquant la migration des monocytes à 
travers le gel. Pour l’alginate, seulement quelques monocytes ont pu être observés près des 
îlots. Des marquages par immunofluorescence ont montré que l'expression d’intégrines était 
plus élevée dans les îlots enrobés dans la fibrine. Un essai TUNEL a révélé un nombre élevé 
de cellules apoptotiques pour les îlots cultivés dans les plaques de TCPS par rapport à ceux 
dans la fibrine et l’alginate. La sécrétion d'insuline était plus élevée chez les îlots intégrés dans 
la fibrine et l'alginate par rapport à ceux non-encapsulés. Des concentrations élevées des 
cytokines TNFα, IL-6 et IL-1β furent mesurées dans les milieux des co-cultures de monocytes 
et des mono-cultures dans la fibrine. 
Conclusion : Les gels d’alginate et de fibrine fournissent un soutien structurel et offrent une 
protection pour les îlots exposés à des monocytes humains. La fibrine seule déclenche la 
sécrétion de cytokines par les monocytes. 
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5.1 Abstract 
 
Aim: To investigate the protective function of alginate and fibrin gels used to embed porcine 
endocrine pancreatic islets towards human monocytes. 
Methods: Groups of 200 islet equivalents from young pigs were embedded in either a fibrin or 
in an alginate gel, and as a control seeded in tissue culture polystyrene (TCPS) well plates. 
The islet cultures were incubated with 2x105 human monocytes for 24 h. In addition, both 
islets and monocytes were separately cultured in TCPS, fibrin and alginate. Islet morphology, 
viability and function were investigated as well as the secretion of cytokines TNFα, IL-6, and 
IL-1β. 
Results: When freely-floating in TCPS, non-encapsulated islets were surrounded by 
monocytes and started to disperse after 24 h. In fibrin, monocytes could be found in close 
proximity to the embedded islets, indicating monocyte migration through the gel. In contrast, 
after 24 h, few monocytes were found close to islets in alginate. Immunofluorescence staining 
and manual counting showed that integrin expression was higher in fibrin-embedded islet 
cultures. A TUNEL assay revealed elevated numbers of apoptotic cells for islets in TCPS 
wells compared to fibrin and alginate cultures. Insulin secretion was higher with islets 
embedded in fibrin and alginate when compared to non-encapsulated islets. TNFα, IL-6 and 
IL-1β were found in high concentrations in the media of co-cultures and monocyte mono-
culture in fibrin. 
Conclusion: Both alginate and fibrin provide key structural support and offer some protection 
for the islets towards human monocytes. Fibrin alone triggers the cytokine secretion from 
monocytes. 
  
 76 
 
5.2 Introduction 
 
For Type 1 diabetic mellitus (T1DM) patients, islet transplantation has the potential to restore 
endogenous insulin secretion in response to glucose [237]. The loss of islet function and 
viability as well as beta cell death often occurs after transplantation. This loss is due to a 
combination of immediate immune rejection of the graft, toxicity of the immunosuppressive 
drugs, lack of islet vascularization, loss of extracellular matrix (ECM) and recurring 
autoimmunity to the beta cells [238]. Monocytes and macrophages play a specific role in the 
rejection process, especially in xenotransplantation. Acting as T cell stimulators via their 
antigen-presenting functions as well as direct destruction, macrophages contribute to xenograft 
rejection in multiple ways [110].  
The introduction of the Edmonton’s protocol substantially improved methods of human islet 
isolation and transplantation immunosuppression protocols as well as the outcomes, making 
more successful islet grafting in T1DM patients [3]. However, long-term follow up of these 
transplanted patients revealed progressive islet graft loss due to multiple factors such as an 
instant blood-mediated inflammatory response, a delay in islet revascularisation, a lack of 
oxygen and nutrient supply, and a recurrence of autoimmunity [239,240]. Consequently, even 
after reception of multiple donor grafts, the majority of recipients resumed exogenous insulin 
dependency alongside with a life-long, possibly damaging immunosuppressive regime. On the 
contrary, most recipients maintained normal C-peptide levels and HbA1c levels, thus 
improving the secondary complications related to T1DM [239]. 
Numerous approaches have been considered to improve current methods of islet 
transplantation. Among the most studied are to micro- or macro-encapsulate endocrine 
pancreatic islets, to identify alternative transplantation sites, and/or to use xenotransplantation 
and considerable efforts in transdifferentiation of stem cells into insulin producing cells. 
Encapsulation approaches are based on the idea of better protecting islets from the recipient’s 
immune system [9,59–62]. Various encapsulation materials have been tested in vitro and in 
vivo, more or less successfully, to improve islet viability and function [9,241,242]. The two 
materials utilized in this particular study are alginate and fibrin hydrogels. 
Alginate systems are very attractive in their abundance, their gelling properties and possible 
biocompatibility [243]. Based on this, alginates are probably the most used biomaterials for 
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cell encapsulation. Islet-alginate capsules transplanted in streptozotocin-induced diabetic 
animals or spontaneous-diabetic animal models were more or less successful [61,244–246] 
depending on the animal model, the purity of the alginate, the composition of the alginate, and 
the islet source, with allogenic grafts being more successful than xenogenic grafts. In a recent 
study, Dufrane et al. transplanted porcine pancreatic islets embedded in an alginate matrix, 
provided with a collagen sheet, into streptotocin-induced diabetic non-human primates without 
immunosuppressive drugs for up to 6 months [61]. An interesting aspect of this study is the 
usage of a collagen matrix. As microencapsulated islets without the collagen matrix lose their 
function after 2 weeks, the positive effects on islet viability and function in the alginate 
monolayer cellular device could at least partly be based on the ECM-islet interaction [60,61]. 
Recent studies have shown that pancreatic islets embedded in fibrin showed improved 
viability, function, and better preserved their native morphology [40,41,43–45,247]. 
Theoretically, fibrin could be used as a scaffold in islet transplantation to help circumvent an 
immune reaction to a foreign source. In vivo, fibrin matrices are the product of fibrinogen 
molecules polymerizing into a cross-linked network after thrombin activation [34]. Fibrin clots 
are very important in wound healing, providing anchorage for platelets, fibroblasts, 
neutrophils and monocytes [37,38]. Fibrin gels can be easily made in vitro. The obtained 
biodegradable fibrin gels are quite similar to in vivo fibrin clots, especially when cells or 
tissues are embedded within [34,39]. Therefore, fibrin scaffolds represent a valuable 
biomaterial for tissue engineering and cell encapsulation, providing a structural support and 
cues from the ECM, and being already widely used in clinical procedures [32,37,40]. On the 
contrary, fibrin clots formed during inflammation in the blood are degraded in a process called 
fibrinolysis which could impair its feasibility as islet graft scaffold [46,47]. 
The aim of this study was to evaluate the protective effects of both alginate and fibrin matrices 
and their interaction with islets and monocytes. Furthermore, the establishment of an in vitro 
model for T1DM and islet graft rejection was targeted. For this, human monocytes were 
separated from whole blood of healthy donors and co-cultured with encapsulated and free 
islets. Monocytes were chosen to represent the immune cells being first at site of an islet graft 
[110,248]. Monocytes also play an important role in T1DM development and cellular response 
to β cell auto-antigens [249]. During a 24h co-culture, islet morphology, monocyte migration 
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and gel structure were under observation. T1DM and transplantation-related cytokines TNFα, 
IL-1β, and IL-6 were measured. 
 
5.3 Materials and Methods 
5.3.1 Isolation of Young Porcine Endocrine Pancreatic Islets 
 
Endocrine pancreatic islets were isolated from pancreata of young Yorkshire pigs (14-22 days) 
by the islet isolation facility at the Dept. of Surgery, University California Irvine, under the 
approval of the University of California Institutional Animal Care and Use Committee 
(IACUC Protocol 2008-2823; Approval Period 09/28/2012-09/27/2013), as described 
previously [250]. 
 
5.3.2 Young Endocrine Porcine Islet Culture 
 
Upon arrival, porcine endocrine pancreatic islets were cultured in RPMI-1640 medium 
(31800-022, Invitrogen, Burlington, ON, Canada) containing 10% human serum AB (HSAB, 
34005100, Invitrogen), 10 mM HEPES (H3375, Sigma-Aldrich, Oakville, ON, Canada), 1% 
penicillin-streptomycin (15140-122, Invitrogen) and 2 mM L-glutamine (25030-149, 
Invitrogen, Burlington, ON, Canada). Islets were either embedded and cultured in fibrin gels 
or alginate gels, or cultured in 48-well TCPS plates. 
 
5.3.3 Separation of Monocytes from Human Whole Blood 
 
Whole blood samples (80 mL) were obtained from both male and female volunteers of various 
ages in Vacutainers. 20 mL of whole blood were poured into 18 mL of PBS and then gently 
mixed. An injection needle with a 20 mL syringe was entered into the tube containing the 
blood/PBS mix and 13 mL of Ficoll-Plaque PlusTM (17-1440-03, GE Healthcare, Baie d’Urfe, 
QC, Canada) were injected at the bottom of the 50 mL Falcon tube to separate red blood cells 
and peripheral blood mononuclear cells (PBMC). The blood-Ficoll mix was then centrifuged 
for 20 min (400 rcf (relative centrifugal force), 22°C, acceleration (acc.) of 3, deceleration 
 79 
 
(dec.) of 0). The PBMC ring was transferred into a fresh 50 mL Falcon tube and rinsed with 
30 mL of PBS buffer followed by 10 min centrifugation (230 rcf, 22°C, acc. 5, dec. 3) and two 
rinses in PBS followed by 5 min centrifugation (230 rcf, 22°C, acc. 5, dec. 3). After rinsing, 
PBMC were re-suspended in un-supplemented RPMI-1640 medium with 1% penicillin-
streptomycin, counted, and then plated into 6-well TCPS plates with 10 million cells per well 
in 2 mL of un-supplemented medium and placed for 1 h in a 37°C cell incubator (5% CO2). 
Monocytes attached to the TCPS whereas lymphocytes stayed in suspension. Hence, 
lymphocytes were removed from the wells to obtain a human monocyte culture. The purity of 
the monocytes were confirmed by flow cytometry using the CD14 surface marker (98%) as 
described in detail elsewhere [251], using the APC/Cy7 anti-human CD14 (301819, 
BioLegend Inc., San Diego, CA, USA). Monocytes were then covered with 2 mL of 
supplemented RPMI-1640 as described above. 
 
5.3.4 Preparation of Fibrin and Alginate Gels Containing Young Porcine 
Endocrine Islets 
 
Fibrin gels with a total volume of 200 µL containing 200 islet equivalents (IEQ) were 
prepared in 48-well TCPS plates as described previously [236]. After 5 min in the cell 
incubator at 37°C, sufficient jellification was obtained and gels were covered with 200 µL of 
medium. 
Alginate gels were prepared using a 3% alginate solution [252]. Briefly, islets were placed into 
the 200 µL alginate drop in 48-well TCPS plates followed by a 5-min incubation with a 120 
mM CaCl2-solution surrounding and covering the alginate drop. After jellification, the excess 
of the CaCl2 solution was removed and gels were covered with 200 µL of medium. An equal 
number of islets was re-suspended in 200 µL of medium and seeded in 48-well TCPS plates. 
See Figure 1 for a schematic picture of the experimental methods. See Supplementary Figures 
5.1 and 5.2 for scanning electron microscopy (SEM) images (Fig. B1) and photographs (Fig. 
B2) of both fibrin and alginate gels prepared as described above. 
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5.3.5 Islet Incubation with Human Monocytes 
 
After complete jellification of both fibrin and alginate gels, media of islets cultures were 
removed and replaced with either 200 µL of medium with no monocytes or 200 µL of fresh 
medium containing 200,000 monocytes. For the TCPS control, islets were suspended in 200 
µL of fresh medium containing monocytes (Fig. 5.1). The islets were then cultured for 24 h. 
Light microscopy images were taken after 8 and 24 hours. 
 
Figure 5.1: Schematic representation of the islet-monocyte co-culture systems with non-
encapsulated islets in a TCPS well and islets encapsulated in fibrin or alginate. Monocytes 
were suspended in the medium and seeded on top of the gels or in suspension with the islets in 
TCPS wells. Controls consisted of islets and monocytes cultured apart from each other in 
TCPS, fibrin, or alginate. The monocyte controls were seeded on top of fibrin or alginate gels 
with no islets.  
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5.3.6 Cytokine Secretion 
 
All media were collected after 24 h and stored at -20°C. A Luminex test was performed for 
TNFα, IL-1β, and IL-6. Using a custom-designed MILLIPLEX MAP kit (HCYTOMAG-60K 
(PX29, PX30, PX38, PX41), EMD Millipore Corporation, Billerica, MA, USA), samples were 
prepared and measured according to manufacturer’s instructions. Briefly, 25 µL of samples 
were plated with 25 µL of a matrix solution (here: cell culture medium). 25 µL of controls and 
standards were plated with 25 µL of assay buffer. Then, 25 µL of mixed fluorescent-coded 
magnetic beads, known as MagPlexTM-C microspheres, were added to each well and incubated 
overnight with agitation at 4°C. After washing, 25 µL of detection antibodies were added and 
incubated with agitation for 1 h at room temperature followed by addition of 25 µL of a 
streptavidin-phycoerythrin solution. After 30-min incubation with agitation at room 
temperature, solutions were removed and the plate was washed twice. 150 µL of sheat fluid 
were added to each well and beads were re-suspended under agitation for 5 min at room 
temperature. The plate was then run using a Luminex® 200™ apparatus (Luminex 
Corporation, Austin, TX, USA) and the Xponent 3.1 software (Luminex Corportation) for 
analysis. 
 
5.3.7 Insulin Secretion from Young Porcine Endocrine Pancreatic Islets 
 
Immediately following the 24-h culture, fibrin and alginate gels were centrifuged for 2 min at 
6,000 rpm to extract insulin trapped within the gels. Then, media of all conditions were 
collected allowing measurement of insulin in both the gel and incubating phases. Insulin 
contents were measured using an Insulin Porcine ELISA kit (0.01 µg L-1 sensitivity; 10-1200-
01, Mercodia Inc., Winston-Salem, NC, USA). Insulin content was normalized to an IEQ for 
each condition. Absorbance was measured using a Safire2 microplate reader (Tecan Group 
Ltd., Männedorf, Switzerland). 
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5.3.8 Immunofluorescence 
 
All samples were collected into centrifuge tubes, fixed in 4% paraformaldehyde and processed 
for paraffin embedding. Immunofluorescence staining was performed according to standard 
protocols with paraffin sections consecutively cut at a thickness of 4 µm [200]. Primary 
antibodies to insulin (ab7842), glucagon (ab18461) and αVβ3 integrin (ab7166) were 
purchased from Abcam (Cambridge, MA, USA). The primary antibodies for the α5 integrin 
(sc-10729) and CD14 (sc-58951) were purchased from Santa Cruz (Santa Cruz, CA, USA). 
Secondary antibodies were obtained from Invitrogen. All sections were blocked in 10% goat 
serum and counterstained with DAPI (D1306, Invitrogen). Manufacturer’s recommendations 
were used for pre-treatment, dilutions, incubation time and temperature. Samples were imaged 
using an epifluorescence microscope (Nikon Eclipse). 
 
5.3.9 TUNEL Apoptosis Assay 
 
Paraffin sections of the young porcine endocrine pancreatic islets cultured in fibrin, alginate, 
or in TCPS plates were treated with the APO-BRDU-IHCTM* kit (AH1001, Phoenix Flow 
Systems, San Diego, CA, USA) to measure apoptosis by dual color immunohistochemistry. 
After rehydration, samples were permeabilized with Proteinase K (1:100 in 10 mM Tris pH 8) 
at room temperature (RT) for 20 min. Endogenous peroxidase inhibition was achieved with 3 
% H2O2 in methanol (at RT for 5 min). 
A 30 min equilibration step followed at RT, with the reaction buffer provided with the kit. 
Then, the DNA labeling solution was applied for 90 min at 37 °C with samples placed in a 
humid chamber. The DNA labeling solution contained reaction buffer, TdT enzyme, Br-dUTP 
and distilled water. A 10-min incubation with blocking buffer at RT was followed by a 90 min 
incubation at RT in a humid chamber with an antibody solution containing anti-BrdU-biotin 
and blocking buffer. The conjugate solution made in blocking buffer was then applied for 30 
min at RT. The DAB solution (DAB/H2O2/Urea in tap water) was incubated for 5 min at RT. 
Samples were rinsed with tap water, and immediately after, covered with a methyl green 
counterstain solution at RT for 5 min. Mounting with a Permount solution (SP15100, Fisher 
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Scientific) was preceded by dipping the samples in 100 % ethanol and later, xylene. Samples 
were imaged with a Leica DMR HCS microscope system. Pictures of at least 10 image 
sections were taken and manually counted for APO-BrdU-positive cells. 
 
5.3.10 Statistical Analysis 
 
Data are presented as means ± standard deviations for 3 independent experiments. Differences 
in results were assessed by a single factor ANOVA. A probability (P) value < 0.05 was 
considered statistically significant and a p < 0.001 was considered highly statistically 
significant. 
 
5.4 Results 
5.4.1 Monocyte Migration Towards Young Porcine Pancreatic Islets 
 
After 8 h, monocytes migrated through the fibrin gel containing islets to close proximity of the 
islets (Fig. 5.2). Similarly, in TCPS, monocytes migrated towards the freely-floating islets 
(Fig. 5.2). In contrast, after 8 h, monocytes were not found in proximity of islets in alginate 
gels, indicating no penetration/migration by monocytes towards the islets within the alginate.  
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Figure 5.2: Morphology of young porcine endocrine pancreatic islets and human monocytes 
cultured for 8 h in TCPS plates, alginate, and fibrin. 20x magnification. Bars represent 50 µm. 
 
After 24 h, few monocytes were found in proximity of islets in alginate (Fig. 5.3, indicated 
with arrows). Dissociation of islets in TCPS wells co-cultured with monocytes was observed 
(Fig. 5.3). 
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Figure 5.3: Morphology of young porcine endocrine pancreatic islets and human monocytes 
cultured for 24 h in TCPS plates, alginate, or fibrin. 20x magnification. Bars represent 50 µm. 
 
5.4.2 Levels of TNFα, IL-1β and IL-6 Secreted by Monocytes are the 
Highest in Fibrin 
 
In both fibrin cultures (i.e., with and with no islets), cytokines TNFα, IL-1β and IL-6 (Fig. 5.4) 
were secreted in high concentrations by monocytes. TNFα was the pro-inflammatory cytokine 
found in the highest concentration when monocytes were cultured in fibrin in the absence of 
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islets. Compared to IL-6 and TNFα, IL-1β levels were the lowest (Fig. 5.4). Comparatively 
low concentrations of the three cytokines were found when monocytes were not added. 
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Figure 5.4: Secretion of cytokines TNFα, IL-6, and IL-1β in the culture media of young 
porcine endocrine pancreatic islets cultured alone or co-cultured with human monocytes, and 
human monocytes cultured alone for 24 h in TCPS plates, alginate, and fibrin. ’*’ represents a 
value of p < 0.05, ‘***’ represents a value of p < 0.001, ‘ns’ represents non-significant. 
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5.4.3 Islets in Fibrin and Alginate are Less Apoptotic than Islets in TCPS 
Plates 
 
Apoptosis staining and counting revealed a lower ratio of apoptotic cells in islets cultured with 
monocytes in both fibrin and alginate when compared to TCPS wells (Fig. 5.5). Apoptosis 
levels were slightly higher for islets in TCPS with no monocytes added, when compared to 
both fibrin and alginate systems. Apoptosis in monocytes was lowest in TCPS (Fig. 5.6). All 
cells in the co-cultures were counted at first, followed by separate counting of the monocytes. 
Of 34,000 cells counted in total in the TCPS set, only 1 % of these cells were monocytes. An 
average of 23 % of the monocytes in the TCPS islets/monocytes co-culture was apoptotic. A 
similar picture was found in fibrin and alginate co-cultures. The percentage of apoptotic 
monocytes in the co-cultures is slightly higher compared to monocytes cultured in the absence 
of islets. 
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Figure 5.5: Light microscopy images of young porcine endocrine pancreatic islets and human 
monocytes treated with the APO-BrdU IHC staining kit to reveal apoptotic cells. TCPS: Islets 
(A), islets+monocytes (B), and monocytes (C). Fibrin: Islets (D), islets+monocytes (E), and 
monocytes (F). Alginate: Islets (G), islets+monocytes (H), and monocytes (I). 40x 
magnification. 
 
 
Figure 5.6: Percentage of apoptotic cells in the indicated cell population of young porcine 
endocrine pancreatic islets and human monocytes either cultured alone or co-cultured in 
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alginate, fibrin and TCPS plates and treated with the APO-BrdU IHC staining kit to reveal 
apoptotic cells. 
 
5.4.4 Islets in Fibrin and Alginate Secrete Higher Levels of Insulin than 
Islets in TCPS 
 
After 24 h of culture, islets cultured in bare TCPS plates secreted significantly less insulin 
when co-cultured with monocytes, whereas the insulin secretion of islets in fibrin did not 
change when monocytes were added. In alginate, islets secreted significantly more insulin in 
the presence of monocytes. Also, islets in fibrin and alginate secreted more insulin per IEQ 
than islets in TCPS (Fig. 5.7). 
 
 
Figure 5.7: Insulin secretion per IEQ from young porcine endocrine pancreatic islets after a 
24-h culture in TCPS, alginate, or fibrin with and with no human monocytes. ’*’ represents a 
value of p < 0.05, ’***’ represents a value of p < 0.001. 
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5.4.5 Integrins αVβ3 and α5 Are Expressed More Profoundly in Fibrin Islet 
Cultures 
 
αVβ3 and α5 integrins were found to be expressed in all conditions (Fig. 5.8). In the presence of 
monocytes, integrin α5 expression was diminished, except in alginate. Integrin αVβ3 expression 
increased in islets in fibrin and on TCPS but decreased slightly in alginate (Table. 5.1). 
Integrin expression in fibrin was overall higher than in islets cultured in TCPS or in alginate 
(Table 5.1). 
 
 
Figure 5.8: Immunofluorescence staining for integrins αVβ3 (green) and α5 (red) of young 
porcine endocrine pancreatic islets after a 24-h culture in TCPS plates, alginate, or fibrin with 
and with no human monocytes. Nuclei are DAPI stained in blue. 20x magnification. 
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Table 5.1: Manual counting of cells in all conditions stained positively for integrins αVβ3 and 
α5. At least 5 random fields per condition were examined, containing an average of 3 islets per 
field. 
 Condition Total number of 
cells counted*  
(100 %) 
Integrin α5 
positive 
cells 
Integrin α5 
positive 
cells (%) 
Integrin 
αVβ3 
positive 
cells 
Integrin 
αVβ3 
positive 
cells (%) 
Time Zero 12,057 5,065 42.1 % 981 8.1 % 
Fibrin Islets 10,542 5,967 56.6 % 959 9.1 % 
Fibrin 
Islets+Monocytes 
7,676 4,120 53.7 % 2,463 32.1 % 
Alginate Islets 4,788 1,606 33.5 % 2,007 41.9 % 
Alginate 
Islets+Monocytes 
5,737 1,602 27.9 %  1,641 28.6 % 
TCPS Islets 16,630 5,397 32.5 % 1,280 7.7 % 
TCPS 
Islets+Monocytes 
12,731 1,714 13.5 % 4,517 35.5 % 
* Variations in the cell numbers counted depend on sample sizes, which vary from one 4µm-
thick paraffin section to another. 
 
5.4.6 CD14 Is Expressed in Both Monocytes and Porcine Pancreatic Islets 
 
An E-cadherin staining was performed to identify the islet population and distinguish it from 
the monocytes. CD14 was found to be expressed in a subpopulation of monocytes and also in 
cells within the islet structure. Single cells observed in proximity of islet structures showed 
positive E-cadherin staining as well (Fig. 5.9).  
A thorough analysis was performed and revealed that CD14 positive cells were indeed found 
within islets, although mostly in dispersing islets of islet/monocyte co-cultures or at the 
periphery of islets (Table 5.2). CD14 could also be found in islets cultured in the absence of 
monocytes but was found to be weak. E-cadherin could be found in cultures of monocytes 
without islets. In fibrin, E-cadherin staining of monocytes alone was weak, whilst it was 
stronger in monocytes in TCPS and in alginate (Table 5.2). 
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Figure 5.9: Immunofluorescence staining for CD14 (green) and E-cadherin (red) of young 
porcine endocrine pancreatic islets after a 24-h culture in TCPS plates, alginate, or fibrin with 
and without human monocytes. Nuclei are DAPI stained in blue. 20x magnification. Bars 
represent 50 µm. 
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Table 5.2: Analysis of islet and monocyte cultures stained for E-cadherin and CD14. At least 5 
images were analysed to estimate staining intensity of both molecules and evaluate islet 
integrity. Symbols signify the following: +++ very strong; ++ strong; + less strong; +/- weak; - 
absent. 
Condition E-
cadherin 
intensity  
CD14 intensity  Islet structure overall No. of 
images  
No. of 
islets 
(total) 
Fibrin: 
Islets and 
monocytes 
+ + 
At the periphery 
of islets. 
In single cells. 
Mostly intact islets 
(Ecad +). Few islets 
show signs of 
dispersion. 
Single cells around 
islets (Ecad+). 
9 66 
Fibrin: 
Islets 
+ +/- 
Overall weak, 
only in a few 
cells at the 
periphery. 
Mostly intact, some 
clusters (Ecad+). 
Few single around 
islets.  
10 49 
Fibrin: 
Monocytes 
+/- 
Weak 
++ 
Only single 
cells.  
- 5 Monocytes 
only 
TCPS: 
Islets and 
monocytes 
++ + 
Inside islets or 
at the periphery. 
On single cells. 
Dispersing islets 
(Ecad+), clustered 
cells and single cells 
around islets. 
10 54 
TCPS: 
Islets 
++ +/- 
At the 
periphery. 
Most islets start 
dispersing, with 
clustered cells 
around islets.  
10 86 
TCPS: 
Monocytes 
+ + 
Single cells. 
- 5 Monocytes 
only 
Alginate: 
Islets and 
monocytes 
++ + 
At the islet 
periphery. On 
single cells 
around islets.  
Mostly intact. 
Clustered cells in 
proximity to islets. 
One dispersing islet. 
8 52 
Alginate: 
Islets 
++ +/- 
Mostly at the 
periphery.  
Mostly intact. 
Clustered cells. 
10 43 
Alginate: 
Monocytes 
+ 
 
+ 
Single cells. 
- 5 Monocytes 
only 
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5.5 Discussion 
 
Encapsulation approaches have gained attention in the islet transplantation community since 
conventional islet transplantation is showing only limited success with i) low rates of graft 
survival in the portal vein, ii) regress to insulin dependency, iii) recurring autoimmunity and 
iv) necessity of multiple donor organs [239]. Xenotransplantation has also moved into the 
spotlight as an alternative cell source for human islets. Porcine islets are considered a valuable 
source due to availability, genetic homology, and an almost analogous insulin molecule 
[253,254]. 
The development of methods to study interactions between endocrine pancreatic islets and 
immune cells is of interest to the pharmaceutical industry, as they could provide models to 
study the effects of therapeutics on diabetes treatment. This would help discriminating 
molecules that should enter pre-clinical testing, thus, reducing the number of animals needed 
for drug development. 
When used before transplantation to embed pancreatic islets, fibrin has been shown to improve 
islet survival, decrease islet apoptosis, increase islet insulin content, and enhance islet 
functionality [40,45]. On the other side, alginate systems used to either macro- or 
microencapsulate islets from human or porcine origin have been tested successfully in vitro 
and in vivo, proving to be biocompatible and to allow temporary immune isolation, improved 
functionality, and easy recovery from the transplantation site [61,252]. Although alginate 
encapsulation of porcine islets, in combination with a collagen sheet, was successful up to six 
months without immunosuppression in non-human primates [61], questions on the interactions 
between materials, the islets and the immune cells remain. 
In this study, maturated young porcine endocrine pancreatic islets encapsulated in fibrin or 
clinical-grade alginate were co-cultured in vitro with human monocytes. After only 8 h of co-
culture, monocytes could be observed within proximity of islets in TCPS well plates and of 
those embedded in fibrin (Fig. 5.2) whereas, with alginate gels, monocytes remained on the 
gel surface. This indicates that monocytes are activated by the fibrin itself [255] and/or 
migrate towards the porcine islets embedded within the fibrin gel, as the control fibrin gels 
(i.e., with no islets) resulted into monocyte invasion. In the case of alginate, it was found that 
highly purified alginate gels, comparable to the one used here, induced little to no immune 
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response [254,256].  Macrophages have been shown to be first on site in the early stages of 
T1DM onset and in insulitis in bio-breeding rats [249]. When co-cultured with monocytes in 
TCPS, islets started disintegrating after 24 h (Fig. 5.3), seemingly due to the lack of support 
from a matrix. 
Monocytes and other immune cells secrete a large variety of cytokines, chemokines, and 
reactive oxygen species [257]. It has been shown that pro-inflammatory cytokines such as 
TNFα, IFNγ, and IL-1β induced apoptosis in vitro in rat and human islets [258]. When 
compared to alginate and TCPS, fibrin resulted in significantly higher monocyte secretion of 
TNFα, IL-6 and IL-1β (Fig. 5.4). In TCPS, islets were cultured directly with monocytes, 
meaning that no physical barrier surrounded the islets. Levels of TNFα, IL-6, and IL-1β were 
elevated compared to those with alginate, but much lower compared to those observed with 
fibrin. This further indicates that monocytic cytokine secretion was activated more by the 
fibrin than by the islets themselves as shown before [259]. Additionally, more IL-6 and TNFα 
was secreted by monocytes in the absence of islets in response to the fibrin gel (Fig.5.4). It is 
hypothesised that islets secrete monocyte-regulating chemokines to answer the 
proinflammatory cytokine storm and therefore contribute to the lower cytokine concentration 
[248]. Further testing of such islet-derived chemokines should be undergone. In contrast, islets 
embedded in fibrin or alginate and co-cultured with monocytes were less apoptotic than islets 
co-cultured with monocytes in TCPS (Fig. 5.5 and Fig. 5.6). More than 60 percent of islet 
cells in the total population were apoptotic when co-cultured with monocytes in TCPS. We 
showed recently that young porcine endocrine pancreatic islets cultured in fibrin exposed to 
two concentrations of hydrogen peroxide (10 and 100 µM) were significantly less apoptotic 
than islets cultured in TCPS [260]. Since fibrin constitutes a transient ECM, islets were 
supposedly able to bind to fibrin using their integrin receptors, supporting islet survival 
[52,60,260]. Here, integrin α5 and αVβ3 expression was enhanced in fibrin cultures (Table 5.1) 
thus most probably preventing cytokine-induced islet cell apoptosis. 
The levels of cytokines found in vitro in the present study are comparatively very high, with 
average levels of 3,196 ± 242 pg/mL of TNFα found in the media of monocytes in fibrin, 
compared to an average of 2.7 ± 0.3 pg/mL TNFα found in plasma of healthy control subjects, 
as reported elsewhere [261,262]. Further investigation should include several time points and 
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prolonged culture time to validate the relatively short half-life of cytokines and fluctuation of 
cytokine secretion over time [261]. 
 TNFα impairs glucose-stimulated insulin secretion of pancreatic beta cells and, in 
combination with IL-1β, IL-6 and IFN-γ, contributes to beta cell destruction by inducing 
apoptosis [263,264]. Insulin concentration was decreased in the media for islets co-cultured 
with monocytes in TCPS (Fig. 5.7) and was much lower overall when compared to fibrin and 
alginate cultures. In alginate, islets secreted significantly more insulin in the presence of 
monocytes. It is hypothesized that occurring cell death or stress possibly led to a release of 
insulin into the surrounding alginate gel. One study supporting this hypothesis showed 
increased insulin secretion in response to stress linked to the endoplasmic reticulum, 
consequently leading to apoptosis [265]. The observation that insulin secretion remained 
stable in fibrin might be due to supporting integrin-fibrin interactions, as integrin expression 
was found to be more pronounced in fibrin cultures (Table 5.1) [208]. Integrins α5 and αVβ3 
could also contribute to improved cell survival. It was shown that re-establishment of the islet 
ECM after disruption during islet isolation is beneficial for maintenance of both in vitro and in 
vivo islet function [229]. Our data suggest that islet cells express more αVβ3 in response to the 
presence of monocytes in both fibrin and TCPS sets (Table 5.1). In the context of 
chondrosarcoma, it was found that TNFα increased αVβ3 expression in chondrosarcoma cells 
[266]. In support, a recent study showed that the monocyte chemoattractant protein-1 (MCP-1, 
also known as chemokine ligand 2, CCL2), primarily secreted by monocytes, macrophages 
and dendritic cells, promoted migration of human prostate cancer cells by enhancing their αVβ3 
expression [267]. Both studies suggest that αVβ3 expression is increased in cancer cells in the 
presence of immune system mediators. In their specific situation, enhanced integrin expression 
serves cancer cell migration and, therefore, metastasis of the cancer cells. In our study, the 
enhanced αVβ3 expression suggests a pro-survival effort of the islet cells by activation the 
beneficial ECM-integrin αVβ3 interaction [268]. In the context of islet transplantation, the lack 
of ECM in the islet graft and, therefore, the lack of pro-survival signalling by integrins 
contribute to the rapid destruction of the injected islet suspension. In a related study, collagen- 
and fibrinogen-like polymers were injected into the portal vein prior to engraftment of 
hepatocytes in rats. RGD-integrin-mediated adhesion to the liver endothelium was remarkably 
enhanced, improving the success of the graft [269]. Even though coating cells with laminin, 
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collagen or fibrinogen-like polymers did not result in improved cell adhesion, this study shows 
that engraftment can be facilitated through the utilization of ECM cues. 
To characterize islet/monocytes culture further, E-cadherin/CD14 co-staining was performed. 
CD14, a co-receptor for lipopolysaccharides expressed mainly by monocytes, was found only 
in a subpopulation of pure monocyte cultures (i.e., monocytes cultured with no islets) (Fig. 
5.9). This observation could be based on findings that CD14 expression of monocytes cultured 
ex vivo decreases with time and absence of inflammatory stimulation [270]. CD14 was also 
found to be expressed by cells within the porcine pancreatic islets (Fig. 5.9). It was shown 
previously that beta cells can have a functional CD14 receptor [271]. On the other hand, the 
cells staining positively for CD14 could be monocytes, which infiltrated the islet clusters. This 
is supported by the finding of CD14 positive cells in dispersed islets in TCPS islet/monocyte 
co-cultures (Table 5.2). E-cadherin was found to be expressed in monocytes as well, more 
strongly in TCPS or alginate, indicating the need of monocytes for cell-cell contacts in the 
absence of valid ECM cues as opposed to fibrin [272].  
Further studies should explore the underlying mechanisms of those endocrine pancreatic islets 
interactions with immune cells. Analysis such as FACS, PCR or Western Blotting remain a 
substantial challenge when working with three-dimensional matrices such as those hydrogels 
used in the present study, which have to be dismantled to access the cells within. In addition, 
distinction between two different tissues used in this co-culture system could further 
complicate such analysis. As mentioned above, the system used in this study could serve as a 
valuable in vitro model for ECM-immune cell interactions, ECM-islet interactions, and the 
dynamics of immune cells towards islet grafts. Research is evolving around the interactions of 
ECM and immune cells and attempts have been made to suppress certain aspects of the 
immune responses e.g., the suppression of gelatinase B (matrix metalloprotease-9) to improve 
islet graft survival by reduced leukocyte migration [195]. Such potential inhibitors and 
regulators of immune cell function and migration could be tested in the system used here first 
to estimate the potential effects and to avoid unnecessary animal testing. 
 
5.6 Conclusions 
In conclusion, this study highlights the potential of both fibrin and alginate to serve as immune 
protective encasement materials for islet transplantation. Fibrin, in particular, could serve as a 
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distraction in the initial attack of the immune system giving islets a better chance to re-
establish a functional vasculature and ECM, as monocytes are attracted and possibly activated 
by the presence of the fibrin. Whilst monocytes are penetrating and breaking the fibrin gel, 
islets are left mostly unaffected in terms of apoptosis and insulin secretion levels as opposed to 
islets in TCPS. Alginate, on the other hand, is a valuable physical barrier for monocytes as no 
migration through the gel could be observed. Levels of islet apoptosis and insulin secretion in 
alginate were comparable to those in fibrin.  
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Chapter 6 
CONCLUSION 
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Conclusions – Français 
 
Cette thèse visant à identifier les mécanismes sous-jacents des interactions de la MEC et des 
cellules dans le contexte de l’encapsulation et de la transplantation d'îlots et le rejet subséquent 
de greffons d’îlots par le système immunitaire. Cette thèse tentait de répondre à certaines des 
limites de la transplantation d’îlots, un traitement alternatif du DT1. 
Le premier travail expérimental du chapitre 3 intitulé « La culture des cellules INS-1 sur des 
surfaces modifiées avec CDPGYIGSR, RGD et fibronectine améliore la sécrétion d’insuline et 
la prolifération cellulaire » a permis d’étudier les interactions de molécules de la MEC i.e., la 
fibronectine, le RGD, et le YIGSR, avec des cellules productrices d'insuline (cellules INS-1) 
afin d’améliorer la prolifération et la fonction de ces cellules. Les molécules de la MEC ont 
été greffées de façon covalente sur des surfaces de CMD pour fournir un environnement bien 
défini aux cellules, car celles-ci ne peuvent adhérer sur les surfaces de CMD sans motifs de la 
MEC. Des plaques de TCPS servaient de contrôles positifs. Des surfaces recouvertes de CMD 
et CMD+RGE servaient de contrôles négatifs sur la base de l'hypothèse que les cellules INS-1 
ne seraient pas capables d’adhérer. Fait intéressant, bien que les cellules INS-1 n’adhéraient 
pas aux surfaces de CMD et de CMD+RGE, celles-ci formaient de denses agrégats en 
suspension. Les agrégats ainsi formés sécrétaient de l'insuline en réponse au glucose et 
proliféraient. Les cellules INS-1 cultivées sur des surfaces recouvertes de fibronectine, RGD et 
YIGSR sécrétaient significativement plus d'insuline en réponse au glucose que les cellules 
INS-1 sur les surfaces de CMD et de CMD+RGE. Le taux net de croissance des cellules était 
le plus élevé sur les surfaces de CMD+RGD et CMD+fibronectine. L’expression du marqueur 
de prolifération Ki-67 était plus élevée sur les surfaces de CMD+YIGSR et dans les plaques 
de TCPS que celles observées sur les surfaces de CMD+fibronectine et de CMD+RGD, 
indiquant un effet positif de l’adhérence des cellules INS-1. Ces résultats illustrent que la 
liaison des cellules à la MEC présente une influence bénéfique sur les cellules INS-1. Ces 
résultats sont confirmés par d’autres études utilisant des approches différentes [24,51,51,52]. 
En outre, dans le cadre de ce travail expérimental, une nouvelle approche pour former des 
pseudo-îlots a été identifiée et cette méthode sera utilisée pour mettre en place des cultures 3D. 
Des recherches futures pourraient utiliser ces surfaces avec différents tissus tels que des îlots 
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pancréatiques natifs. En plus, on pourrait disperser les îlots et tester la capacité des cellules des 
îlots pancréatiques à se réorganiser sur des surfaces recouvertes de CMD.  
Il faut mentionner ici que, même prometteurs, ces résultats sont limités du fait que les cellules 
INS-1 sont non seulement une lignée de cellules cancéreuses, mais également dérivées de 
pancréas de rat. L’immortalisation de lignées cellulaires altère éventuellement la morphologie 
des cellules, et peut même changer l’expression épigénétique protéinique [273]. Pour faire des 
conclusions valables sur le comportement des cellules bêta pancréatiques humaines envers des 
surfaces recourvertes de CMD spécifiquement modifiés, d'autres expériences doivent être 
menées. En outre, le travail a été réalisé dans un système de culture en deux dimensions (2D). 
Ces conditions ne reflètent pas bien les conditions des cellules in vivo ainsi que les structures 
d'îlots pancréatiques globulaires et les interactions avec leur MEC. Il a été montré par Sabra et 
Vermette (2012) [274] que les surfaces de CMD+RGD pourraient également être utilisées 
dans un système en trois dimensions (3D) de co-culture avec des cellules endothéliales pour 
étudier la réponse des cellules INS-1, étendant les possibilités pour de nouvelles applications. 
Basée sur les résultats du premier travail expérimental décrit dans le chapitre 3, la deuxième 
étude expérimentale du chapitre 4 intitulé « L’enrobage dans la fibrine d’îlots pancréatiques 
endocriniens isolés de jeunes porcs et exposés au peroxyde d’hydrogène améliore la survie et 
les fonctions des îlots »" a été réalisée. Nous avons émis l’hypothèse que la fibrine, qui 
constitue une MEC transitoire, permettrait d'améliorer la survie, la viabilité et la fonction des 
îlots dans des conditions de stimuli apoptotiques. Donc, dans cette étude, des îlots 
pancréatiques étaient enrobés dans des gels de fibrine et exposés à du peroxyde d’hydrogène 
(H2O2) pour reproduire un environnement apoptotique qui peut être rencontré avec la réponse 
immunitaire observée lors de la transplantation d'îlots pancréatiques endocriniens. Au cours 
d'une période de 12 h, les îlots cultivés dans les gels de fibrine conservaient leur structure 
sphérique typique. Les cellules des îlots enrobés dans la fibrine étaient les moins apoptotiques 
et leur sécrétion d'insuline par rapport à la réponse au glucose était maintenue lorsque celle-ci 
était comparée aux îlots cultivés dans des plaques de TCPS. La fibrine a servi dans des 
procédures chirurgicales et a été utilisée avec succès pour la culture d’îlots avant la 
transplantation [37,44,45,275–278]. Ces études confirment le potentiel de la fibrine comme 
matériau d'encapsulation et sont en accord avec notre étude.  
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Cette étude de concept simple était limitée par le fait que le H2O2 est seulement une des très 
nombreuses molécules impliquées dans la très complexe réponse du système immunitaire. Le 
temps de culture et le temps d'exposition étaient plutôt courts, mais ceux-ci ont été 
sélectionnés pour refléter la réaction initiale du système immunitaire d'un hôte par rapport à 
des greffons tissulaires. Néanmoins, les résultats du chapitre 4 étaient prometteurs, indiquant 
que la fibrine pouvait offrir un certain niveau de protection pour les îlots lorsque ceux-ci sont 
exposés à des stimuli apoptotiques. Donc, l’utilisation de la fibrine pour enrober les îlots a été 
poursuivie dans le chapitre 5. La dernière étude expérimentale de cette thèse est donc intitulée 
«  L’enrobage dans la fibrine et l’alginate d’îlots pancréatiques endocriniens isolés de jeunes 
porcs offre une protection pour les îlots lorsqu’exposés à des monocytes humains ». L’alginate 
a été utilisée pour des fins de comparaison avec la fibrine, étant un matériau traditionnellement 
utilisé pour enrober des îlots [61,252,279]. Les îlots enrobés et non-enrobés étaient cultivés en 
présence de monocytes humains pendant une période de 24 h. Une mesure des cytokines pro-
inflammatoires TNFα, IL-6 et IL-1β a révélé de grandes concentrations sécrétées dans les 
milieux d'îlots intégrés dans la fibrine et dans les milieux de monocytes cultivés sur des gels 
de fibrine « vides ». Ces résultats indiquent que la sécrétion des cytokines par des monocytes 
était déclenchée par la fibrine seule. Au contraire, les îlots enrobés dans la fibrine ainsi que 
ceux dans l’alginate étaient moins apoptotiques que les îlots dans les plaques de TCPS, avec 
ou sans monocytes. La sécrétion de cytokines par les monocytes était légèrement plus élevée 
en réponse à des îlots dans les plaques de TCPS, mais nettement moindre que dans celle 
observée avec la fibrine. L’analyse de l’expression d’intégrines a révélé une élévation de 
l’expression des intégrines αVß3, dépendant de la présence des monocytes, et ce dans toutes les 
conditions. L’activation des intégrines a un effet pro-survie sur les cellules pancréatiques 
[51,214,268]. Seuls les îlots dans la fibrine ont montré une expression élevée de l'intégrine par 
rapport au « temps zéro ». Les îlots dans l’alginate exprimaient un niveau plus élevé 
d’intégrines en comparaison avec les îlots cultivés dans les plaques de TCPS. Comme indiqué 
dans le chapitre 1 de cette thèse intitulé "Interactions entre la matrice extracellulaire et le 
système immunitaire dans le contexte de la transplantation d’îlots pancréatiques endocriniens", 
les monocytes doivent utiliser les intégrines pour fonctionner. Il existe aussi une fonction 
inverse entre les cytokines qui activent l’expression des intégrines et l’activation d’intégrines 
qui déclenche la sécrétion des cytokines. Les interconnexions entre les matériaux utilisés pour 
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encapsuler des îlots, les cellules immunitaires et les tissus encapsulés, ainsi que l'implication 
des intégrines respectives, doivent être étudiées pour mieux cerner les conditions idéales pour 
la transplantation d'îlots pancréatiques. 
Même si prometteuse, l'étude finale de cette thèse a quelques limitations dans la conception de 
certaines expériences. Des gels de petite taille étaient utilisés avec un nombre relativement 
limité d'îlots. Aussi, un temps de culture court ainsi qu’une période de co-incubation courte 
étaient appliqués. La réponse du système immunitaire envers une allogreffe est complexe, 
agressive et se déploie à travers plusieurs types de cellules, impliquant une grande variété de 
cytokines, de chimiokines et d’anticorps [5] et ne peut être facilement reproduite in vitro. 
Ensuite, la taille des gels et le nombre d’îlots encapsulés utilisés pour cette étude ne reflètent 
pas bien le scénario d’une vraie transplantation car le nombre d’îlots nécessaires pour une 
greffe réussie est beaucoup plus élevé [238]. 
L’utilisation des monocytes isolés du tissu sanguin humain avec des îlots porcins n'est qu'une 
première étape vers une modélisation complexe du rejet d’une greffe d’'îlots ou même du 
DT1. Un autre problème à régler dans la conception expérimentale de cette étude est 
l'utilisation du fibrinogène bovin et de la thrombine bovine avec des monocytes humains, et 
d’îlots pancréatiques de porc. Cette situation particulière pourrait effectivement contribuer à la 
réaction des monocytes envers les gels de la fibrine. Puisqu’un des futurs scénarios possibles 
dans le contexte de l’encapsulation d’îlots pourrait impliquer le fibrinogène dérivé du patient, 
les études futures en utilisant une configuration similaire devraient en tenir compte. En ce qui 
concerne l'alginate, la concentration, la pureté et la source semblent jouer un rôle majeur dans 
la faisabilité pour la transplantation d'îlots. L’alginate ultra-pur a été utilisé pour cette étude, ce 
qui pourrait expliquer la faible réponse des monocytes. Il reste à examiner si les systèmes à 
base d'alginate sont égaux ou supérieurs aux systèmes à base de fibrine et comment la 
disponibilité des indices de la MEC modifie l'utilité des approches d'encapsulation. 
En conclusion, cette thèse permet de mettre en évidence le potentiel de la fibrine et de 
l’alginate pour enrober des îlots dans une perspective d’étudier le rôle bidirectionnel de la 
MEC dans la réponse immunitaire et la transplantation d’îlots. Il était montré que les 
interactions entre la MEC et les cellules d’îlots contribuent à l'amélioration de la survie et à la 
fonction des cellules d’îlots. D'un autre côté, la présence de la MEC est nécessaire pour 
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assurer la fonction des cellules immunitaires et pourrait donc faciliter la réponse immunitaire 
vers les tissus implantés. 
Des recherches plus approfondies sont à prévoir pour identifier le matériau idéal pour 
encapsuler des îlots combinant fonctionnalité et protection immunitaire. Une approche 
d'encapsulation fonctionnelle permettrait au glucose, aux nutriments et à l’oxygène d'entrer et 
à l'insuline et aux déchets de sortir, fournirait un soutien structurel et bio-fonctionnel (ex. : 
modulation des intégrines), et faciliterait la revascularisation des îlots. Un matériau 
d'encapsulation idéal pour la protection immunitaire des îlots empêcherait les cellules 
immunitaires d’atteindre les greffons d'îlots, ou distrairait la réponse immunitaire initiale pour 
permettre un meilleur greffage. On espère que les progrès dans le domaine de l'encapsulation 
d’îlots mèneront au succès de la xénotransplantation dans le futur. Ceci pourrait résoudre le 
problème de pénurie de dons d’organes et, enfin, d’offrir un traitement potentiel pour les 
patients atteints du DT1. 
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Conclusion – English 
 
This thesis aimed to identify the mechanisms underlying ECM-cell interactions in the context 
of islet encapsulation and transplantation as well as subsequent graft rejection by the immune 
system. It was attempted to address some of the limitations of islet transplantation, an 
alternative treatment of T1DM. 
The first experimental work of Chapter 3 entitled, "Culturing INS-1 Cells on CDPGYIGSR-, 
RGD- and Fibronectin Surfaces Improves Insulin Secretion and Cell Proliferation" 
investigated the interactions of ECM molecules and proteins, i.e. fibronectin, RGD, and 
YIGSR, with insulin-producing rat insulinoma cells (INS-1) to improve cell proliferation and 
function. ECM cues were covalently grafted on CMD surfaces to provide a well-defined 
environment as cells were assumed to be only able to bind to their respective ECM moieties 
with CMD surfaces being low-fouling. Cells were not able to bind to CMD surfaces. TCPS 
served as positive control for normal cell growth and function of the adherent INS-1 cell line. 
CMD, for reasons described above, and CMD surfaces bearing RGE served as negative 
controls based on the assumption that INS-1 cells would not function and proliferate in 
suspension. Interestingly, INS-1 cells indeed did not attach to CMD- and CMD+RGE-covered 
surfaces but formed dense cell clusters in suspension, later found to secrete insulin in response 
to glucose and even proliferate. INS-1 cells cultured on CMD surfaces covered with 
fibronectin, RGD and YIGSR secreted significantly more insulin in response to glucose than 
INS-1 cells on CMD or CMD+RGE. Net cell growths were the highest on CMD+RGD and 
CMD+fibronectin and Ki-67 proliferation marker expression was the highest on 
CMD+YIGSR and TCPS, indicating an adherence-dependent positive effect on INS-1 cells. 
These results were promising, showing that ECM binding exhibited a beneficial influence on 
INS-1 cells confirming results of similar studies using different approaches [24,51,51,52]. In 
addition, in the course of this experimental work, a novel approach for pseudo-islet formation 
was found which could be studied further and used in 3D cultures or other related research 
projects. Future research could use these surfaces with different tissues such as primary 
endocrine pancreatic islets. Dispersing islets and testing the islet cells’ ability to re-arrange on 
CMD surfaces could also be of interest. It should be mentioned here that, though promising, 
these results are limited to the fact that INS-1 cells are not only a cancerous cell line but are 
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also derived from rat pancreas. Immortalization of cell lines possibly results in alterations in 
cell morphology, epigenetics and maybe even protein expression [273]. To make valid 
conclusions concerning the behavior of human pancreatic beta cells towards the specifically 
modified CMD surfaces, further experiments have to be conducted. In addition, our work was 
performed in a simple 2D set-up, though in a well-defined culture environment, and it does not 
reflect in vivo conditions of neither cells nor pancreatic globular islet structures within the 
complex 3D cell-ECM construct. It has been shown by Sabra and Vermette (2013) [274] that 
CMD-RGD surfaces could also be used in a 3D endothelial co-culture system, studying the 
INS-1 cell response, extending the possibilities for further applications. 
Based on results and limitations of the first experimental work described in Chapter 3, the 
second experimental study (Chapter 4) has been designed and is entitled "Young Porcine 
Endocrine Pancreatic Islets Cultured in Fibrin Show Improved Resistance Towards Hydrogen 
Peroxide". It was hypothesized that fibrin, as a transient ECM, would improve islet survival, 
viability and function in possible apoptotic conditions. This was an attempt to embed 
pancreatic islets in a 3D fibrin gel with ECM properties to challenge the concept of islet 
encapsulation. Islets were exposed to H2O2 to mimic one aspect of the immune response in 
islet transplantation and T1DM. Over a 12-h culture period, islets in fibrin maintained their 
typical spherical structure and exhibited lower levels of apoptotic cells and higher relative 
insulin secretion in response to glucose when compared to islets in TCPS plates. Fibrin has 
already served in surgical procedures and was used to culture islets before transplantation 
[37,44,45,275–278], confirming our results and its potential as encapsulation material. This 
simple concept study was limited in the fact that H2O2 constitutes only one molecule in the 
very complex immune system response. Culture and exposure time were rather short, but were 
selected to reflect the initial reaction of a host’s immune system towards implanted tissues. 
Nonetheless, the results were promising in terms of immune protection of islets by fibrin. 
Consequently, monocytes as cellular mediators of the human immune system were used in the 
third and final experimental study (Chapter 5) to challenge the islets further. This chapter is 
entitled "Young Porcine Endocrine Pancreatic Islets Cultured in Fibrin and Alginate Gels 
Show Improved Resistance Towards Human Monocytes". Alginate was used as second 
candidate for islet encapsulation based on recent studies and its use to encapsulate islets 
[61,252,279]. Islets were embedded in fibrin or alginate gels and co-cultured with human 
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monocytes for 24 h. Measurement of the pro-inflammatory cytokines TNFα, IL-6 and IL-1β 
revealed high secreted concentrations in the media for fibrin-embedded islets and in the media 
of monocytes seeded on “empty” fibrin gels, indicating an activation of the monocyte cytokine 
release by the presence of fibrin. In contrast to these findings, fibrin-embedded islets, as well 
as alginate-embedded islets, showed less apoptotic cells when compared to islets in TCPS 
plates, with and without monocytes. Cytokine secretion by monocytes was slightly elevated in 
response to islets in TCPS plates but significantly less than that in the fibrin set. Evaluation of 
the expression of integrins in all conditions, including islets fixed at arrival (”time zero”), 
revealed a monocyte-dependent elevation of αVβ3 integrin expression in all conditions 
underlining the postulated pro-survival function of integrin activation [51,214,268]. Only 
islets in fibrin showed an overall elevated integrin expression when compared to “time zero”. 
Alginate-embedded islets expressed higher levels of integrins than TCPS-cultured islets. As 
shown in Chapter 1 of this thesis entitled “Cross Talk Between the Extracellular Matrix and 
the Immune System in the Context of Endocrine Pancreatic Islet Transplantation” immune 
cells i.e., monocytes, utilize integrins to exhibit their function and there is a reciprocal function 
of cytokines activating integrin expression and being secreted after integrin activation. Those 
interconnections between encapsulation materials, immune cells and embedded tissues, as well 
as the utilization of their respective integrins, have to be investigated further to develop ideal 
islet encapsulation strategies and islet transplantation conditions.  
Even though promising, the final study of this thesis had its limitations in the setup of small-
sized gels, relatively low islet numbers, and short co-incubation times. The response of the 
immune system towards an allograft is complex, aggressive and unfolds through several cell 
types, a plethora of chemokines, cytokines and antibodies [5] and cannot be easily reproduced 
in vitro. Using blood-derived human monocytes with porcine islets is a first step towards a 
complex modelling of islet graft rejection or even T1DM. Another issue to address in the setup 
of this study is the use of bovine fibrinogen and thrombin, human monocytes, and porcine 
pancreatic islets. This specific situation could actually contribute to the monocytes reaction 
towards the fibrin. Size of gels and number of islets embedded do not reflect the real islet 
transplantation sufficiently. For a successful graft, a high number of transplanted islets is 
necessary [238]. Since one of the possible future islet encapsulation scenarios could involve 
patient-derived fibrinogen, future studies using a similar setup should consider this. 
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Concerning the alginate, concentration, purity and source seem to play a major role in its 
usefulness for islet transplantation. The use of ultrapure alginate for this study could possibly 
explain the low-level response of monocytes. It remains to be examined if alginate-based 
systems are equal or superior to fibrin-based systems and how the availability of ECM cues 
alters the usefulness of encapsulation approaches. 
In conclusion, this thesis offers evidence for the potential use of fibrin and alginate as 
encapsulation materials. It also provides a detailed perspective on the bidirectional roles of the 
ECM in the context of an immune system response and in islet transplantation. On one side, 
ECM-islet cell interactions contribute to improved islet cell survival and insulin secretion. On 
the other side, ECM presence is necessary for immune cell function and could therefore 
facilitate the immune response towards implanted tissues. 
More detailed research has to be carried out to find better materials for islet encapsulation 
combining functionality and immune protection. A functional encapsulation approach would 
allow glucose, nutrients, and oxygen to enter as well as insulin and wastes to exit, would 
provide mechanical, structural and integrin-related islet support, and would facilitate re-
vascularisation of islets. Encapsulation materials for immune protection would ideally hinder 
immune cells to reach the islet graft, or would distract the initial immune response to allow for 
better engraftment. Advances in the field of islet encapsulation will hopefully lead to 
successful and safe xenotransplantation one day, solving the problem of organ donor shortage 
and finally providing a potential cure for T1DM patients. 
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Appendix A 
 
 
Figure A1: Immunofluorescence staining for Ki-67 of INS-1 cells cultured for 7 days on TCPS 
and RGE. Nuclei are stained with DAPI (blue). 60x magnification. Bars correspond to 50 µm. 
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Figure A2: Expression of integrins α5 (red) and αVβ3 (green) of INS-1 cells cultured for 7 days 
on the different surfaces. Nuclei are stained with DAPI (blue). 100x magnification. Bars 
correspond to 50 µm. 
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Figure A3: Expression of integrins α5 (red) and αVβ3 (green) of INS-1 cells cultured for 3 days 
on the different surfaces. Nuclei are stained with DAPI (blue). 100x magnification. Bars 
correspond to 50 µm. 
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Figure A4: Immunofluorescence staining for E-cadherin of INS-1 cells cultured for 3 days. 
Nuclei are DAPI stained in blue. 100x magnification. Bars correspond to 50 µm. 
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Figure A5: Immunofluorescence staining for insulin of INS-1 cells cultured for 7 days on 
fibronectin. Nuclei are stained with DAPI (blue). 60x magnification. Bar corresponds to 50 
µm. 
 
 
Figure A6: Immunofluorescence staining for Pdx1 of INS-1 cells cultured for 7 days on 
CDPGYIGSR and RGE. Nuclei are stained with DAPI (blue). 60x magnification. Bars 
correspond to 50 µm. 
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Appendix B 
 
 
Figure B1: SEM images of fibrin and alginate gels. 1,200 and 2,000x magnification. 
 
 
Figure B2: Photography of fibrin and alginate gels in a 12-well plate. 
